###begin article-title 0
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 112 117 <span type="species:ncbi:9606">human</span>
Multimolecular complex of Par-4 and E2F1 binding to Smac promoter contributes to glutamate-induced apoptosis in human- bone mesenchymal stem cells
###end article-title 0
###begin p 1
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 686 691 686 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 731 735 731 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 762 767 762 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 822 826 822 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 888 893 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 964 968 964 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1034 1039 1034 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1043 1047 1043 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1107 1112 1107 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1190 1195 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1226 1230 1226 1230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 141 146 <span type="species:ncbi:9606">Human</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 897 902 <span type="species:ncbi:9606">human</span>
###xml 1302 1307 <span type="species:ncbi:9606">human</span>
Neural cells undergo glutamate-induced apoptosis in ischaemic brain tissue, in which prostate apoptosis response-4 gene (Par-4) is involved. Human-bone mesenchymal stem cells can be utilized as an effective therapy for ischemic brain injury. In this study, we found that glutamate could induce apoptosis in human-bone mesenchymal stem cells, accompanied by increased expression of Par-4 gene and Smac release from mitochondria. Repressing Par-4 expression attenuated the glutamate-induced apoptosis. Both Par-4 protein and E2F1 protein could bind to E2F1-binding BS3 site on Smac promoter and participated in the formation of a proteins-DNA complex. Moreover, in the complex, E2F1, not Par-4, was found to be directly bound to the Smac promoter, suggesting that Par-4 exerted indirectly its transcriptional control on the Smac gene though interacting with E2F1. Expression of full-length Par-4 in human-bone mesenchymal cells resulted in increased activity of the Smac promoter. In addition, the indirect transcripional regulation of Par-4 on Smac depended on its COOH terminus-mediated interaction between Par-4 and E2F1. We conclude that the formation of proteins-DNA complex, containing Par-4 protein, E2F1 protein and the Smac promoter, contributes to the pro-apoptotic effect on glutamate-treated human-bone mesenchymal stem cells.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 192 200 <span type="species:ncbi:9606">children</span>
###xml 284 289 <span type="species:ncbi:9606">Human</span>
As a major contributor to death and disability, ischaemic brain injury does not only affect adults (1,2), it is also an important cause of mortality and severe neurodevelopmental morbidity in children, such as cerebral palsy, mental retardation, epilepsy and learning disability (3). Human-bone mesenchymal stem cells (hBMSCs) are self-renewing multipotent cells, which can be utilized as an effective therapy for ischemic brain injury. However, although considerable studies have been devoted to investigating the therapeutic efficacy of hBMSCs transplantation in ischemic brain, rather less attention has been paid to the biochemical regulation of the stem cell itself in a pro-apoptotic microenvironment of ischaemic brain tissue. Thus, it is of paramount importance to investigate the events and factors that predispose hBMSCs to undergo apoptosis in ischaemia tissue.
###end p 4
###begin p 5
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
Glutamate, an excitatory amino acid, binds to postsynaptically located glutamate receptors that regulate calcium channels in ischaemic brain tissue. The resulting calcium influx activates proteases, lipases and endonucleases, which in turn destroy the cellular skeleton, finally leading to cells necrosis or switch on apoptosis (4). The implanted stem cells will suffer from the impairment of excitotoxic glutamate as well in such a microenvironment. Hence, for alleviating suffering and improving survival of implanted cells in ischaemic brain tissue, it is important to determine how hBMSCs respond to glutamate.
###end p 5
###begin p 6
###xml 4 40 4 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">prostate apoptosis response factor-4</italic>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
The prostate apoptosis response factor-4 (Par-4) gene was originally identified by differential screening for up-regulated genes in apoptotic prostate cell (5). Subsequently, Par-4 was found to possess potent apoptotic activity in various cellular systems. In the past few years, several studies have investigated the role of Par-4 in cell apoptosis and found that Par-4 had been attributed a crucial function to its COOH terminus domain (6,8). One of the most noticeable structural features of Par-4 COOH terminus was the leucine zipper repeats, a putative death domain, which was found in several other proteins involved in apoptosis, suggesting the importance of this region in Par-4 function (7,9). However, despite the advances made in understanding the role of Par-4 in apoptosis, little was known about whether Par-4 is involved in the response of glutamate-treated hBMSCs.
###end p 6
###begin p 7
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 10 58 10 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">second mitochondria-derived activator of caspase</italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIABLO</italic>
###xml 83 121 83 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">direct IAP-binding protein with low pI</italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 692 696 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
Smac (the second mitochondria-derived activator of caspase), also known as DIABLO (direct IAP-binding protein with low pI), is a pro-apoptotic protein and is normally compartmentalized and stored in mitochondria upon receiving apoptotic stimuli; Smac is released into cytosol, where it binds to IAPs, and active caspases either by eradicating the binding capability of IAPs to caspases or enhancing the proteosome-mediated degradation of IAPs (10,11). In addition, E2F1, a member of E2F transcription factor family, can bind to the Smac promoter and transcriptionlly upregulate Smac expression, which results into the mitochondria-mediated apoptosis (12). However, it remains unclear whether Smac plays a role in glutamate-induced hBMSCs apoptosis.
###end p 7
###begin p 8
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 475 480 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 519 524 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
In this study, we demonstrate for the first time that excitotoxic glutamate can induce hBMSCs apoptosis, accompanied by increased expression of Par-4 and Smac release from mitochondria. Our results indicate that the glutamate-induced pro-apoptotic effect on hBMSCs is partially due to the formation of multimolecular complex of Par-4, E2F1 and Smac promoter. Our results show that Par-4 can transcriptionally modulate Smac expression through the indirect interaction between Par-4 and Smac promoter. The association of Par-4 with E2F1 which depended on the COOH terminus of Par-4, enhances the capability of E2F1 binding to Smac promoter. In conclusion, our findings provided the detailed molecular mechanisms responsible for glutamate-induced apoptosis in hBMSCs.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Reagents and antibodies
###end title 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 6 12 <span type="species:ncbi:9986">rabbit</span>
###xml 39 45 <span type="species:ncbi:9986">rabbit</span>
###xml 91 97 <span type="species:ncbi:9986">rabbit</span>
Par-4 rabbit polyclonal antibody, E2F1 rabbit polyclonal antibody and FITC conjugated anti-rabbit IgG secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The majority of reagents used for this study, including glutamate and DAPI, were obtained from Sigma-Aldrich (St Louis, MO, USA). Anti-CD105 (endoglin), -CD73, -CD106 (VCAM-1), -CD44,-CD90, -CD29, -CD45, -CD14, -CD34, -CD80, -CD86 antibodies, were purchased from BD Biosciences (La Jolla, CA, USA). pGEMT-easy vector, Gel Shift Assay kit, pGL3 Luciferase Reporter Vector were obtained from Promega (Madison, WI, USA). Advantage 2 DNA polymerase and pcDNA3.1/myc-his vector were obtained from BD Biosciences (La Jolla, CA, USA). Restriction endonucleases were purchased from New England BioLab (Beverly, MA, USA). Endo-free Plasmid Maxi kit was obtained from Qiagen (Hilden, Germany). Lipofectamine 2000 reagent was obtained from Invitrogen (Carlsbad, CA, USA). Nuclear Protein Extraction kit was purchased from Active Motif (Carlsbad, CA, USA).
###end p 11
###begin title 12
Cell culture and hBMSCs phenotype analysis
###end title 12
###begin p 13
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 486 487 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 860 861 833 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 407 411 <span type="species:ncbi:9913">calf</span>
Culture and characterization of hBMSCs were performed as described previously (13). Briefly, bone marrow cells were obtained from 5 ml aspirates from the iliac crest of normal donors after informed consents were given. Cells were plated at a density of 5 x 106 per 25 cm2 flask in 5 ml Dulbecco's modified Eagle's medium (DMEM) supplemented with 100 mug/ml penicillin, 100 mug/ml streptomycin and 10% fetal calf serum, incubated at 37degreesC in a humidified atmosphere containing 5% CO2. After 72 h, non-adherent cells were discarded and adherent cells were washed gently with DMEM medium and cultured for approximately21 days. The culture medium was replaced with fresh complete medium twice a week. Upon reaching near confluence, cells were detached with a solution of 0.25% trypsin and 100 muMol/l EDTA for 2-3 min at 37degreesC and plated at 1000 cells/cm2 with medium replacement twice a week. Cells used in our experiments were the fifth or sixth passage of cultivation. hBMSCs were immunophenotyped by fluorescence-activated cell sorting (FACS). Cells were detached with trypsin-EDTA, washed in PBS, and immediately stained with the following labelled antibodies: CD105-FITC, CD73-FITC, CD44-FITC, CD90-FITC, CD147-FITC, HLA Class I-FITC, CD29-FITC, CD34-PE, CD45-PE, CD14-PE, CD11b-PE and HLA-DR-PE and then analysed using a flow cytometry.
###end p 13
###begin title 14
Fluorescence-activated cell sorter analysis
###end title 14
###begin p 15
hBMSCs were harvested in the presence or absence of 1-100 muM glutamate for 6, 12 or 24 h. Cells were collected by trypsinization and washed in PBS. After incubation with 5 mul of Annexin V-FITC and 10 mul of propidium iodide (PI, 50 mug/ml) at room temperature for 15 min in the dark, cells were analysed by flow cytometry. The percentages of apoptosis in the cells were calculated by data from FACS analysis and the result is presented in the bar graph relative to the apoptotic cell rate in hBMSCs without treatment of glutamate.
###end p 15
###begin title 16
DNA fragmentation assay
###end title 16
###begin p 17
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 303 304 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
DNA fragmentation was assessed using a soluble DNA preparation as previously described (14). hBMSCs were harvested in the presence or absence of 100 muM glutamate for 24 h. Then cells were lysed in 10 mM Tris-HCl (pH 7.5) containing 10 mM EDTA and 0.2% Triton X-100. The lysate was centrifuged at 12 000g for 10 min. The supernatant was treated with proteinase K (0.3 mg/ml) and RNase A (0.3 mg/ml) and then extracted in the presence of 300 mM NaAc. The DNA was precipitated with isopropanol and dissolved in 10 mM Tris-HCl (pH 8.0) containing 100 muM EDTA. The DNA was electrophoresed in 1.5% agarose gel in Tris borate-EDTA buffer. The DNA bands were then imaged by ethidium bromide staining and photographed.
###end p 17
###begin title 18
Subcellular fractionation
###end title 18
###begin p 19
###xml 306 307 304 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 412 413 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Cells were washed once in PBS and harvested in isotonic buffer (250 mM sucrose, 1 mM EDTA and 10 mM HEPES, pH 7.4) supplemented with 0.25 mM phenylmethylsulfonyl fluoride, 10 mug/ml leupeptin and 10 mug/ml aprotinin. After a brief sonication, samples were transferred to 1.5-ml tubes and centrifuged at 900g for 10 min at 4degreesC to eliminate nuclei and unbroken cells. Supernatant was then centrifuged at 9500g for 15 min at 4degreesC to obtain the heavy membrane pellet enriched for mitochondria, and the resulting supernatant was stored as the cytosolic fraction.
###end p 19
###begin title 20
Western blotting analysis
###end title 20
###begin p 21
###xml 752 756 750 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 654 665 <span type="species:ncbi:3704">horseradish</span>
Cells were collected by trypsinization and washed in PBS. Then cell pellets were lysed in 1% Nonidet P-40 lysis buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0), to which 2 mM phenylmethylsulfonyl fluoride, 3.3 mug/ml leupeptin and 5 mug/ml pepstatin were added fresh before use. Fifty micrograms of proteins was loaded on precast SDS/Tris/glycine gels, and after electrophoresis, proteins were transferred to nitrocellulose membranes, which were blocked in 5% non-fat dry milk and blotted with the appropriate primary antibody. Membranes were then incubated with the appropriate secondary antibody linked to horseradish peroxidase and developed using the ECL kit according to the manufacturers' protocols. Smac levels were represented as ratios between the levels in mitochondria versus cytosol.
###end p 21
###begin title 22
Small interfering RNA-based (siRNA) experiments
###end title 22
###begin p 23
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 82 87 <span type="species:ncbi:9606">human</span>
A small interfering RNA-based (siRNA) strategy was employed to silence endogenous human Par-4 in hBMSCs. Par-4 and scrambled siRNAs were generated using the procedure of siSTRIKEtrade mark U6 Hairpin Cloning Systems (Promega, Madison, WI). The four siRNAs had the following sense strand sequences:
###end p 23
###begin p 24
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4-siRNA-1:
###end p 24
###begin p 25
###xml 7 27 7 27 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCACAGCCGTTTGAATATAT</underline>
5'-ACCGTCACAGCCGTTTGAATATATTTCAAGAGAATATATTCAAACGGCTGTGACTTTTTC-3'.
###end p 25
###begin p 26
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4-siRNA-2:
###end p 26
###begin p 27
###xml 7 27 7 27 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAAACGAGAAGATGCAATTA</underline>
5'-ACCGGAAACGAGAAGATGCAATTATTCAAGAGATAATTGCATCTTCTCGTTTCCTTTTTC-3'.
###end p 27
###begin p 28
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4-siRNA-3:
###end p 28
###begin p 29
###xml 7 27 7 27 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGAGACTGATGCAAGATAAA</underline>
5'-ACCGTGAGACTGATGCAAGATAAATTCAAGAGATTTATCTTGCATCAGTCTCACTTTTTC-3'.
###end p 29
###begin p 30
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4-siRNA-4:
###end p 30
###begin p 31
###xml 7 27 7 27 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AACAGTTTCAGGCAGATATA</underline>
5'-ACCGAACAGTTTCAGGCAGATATATTCAAGAGATATATCTGCCTGAAACTGTTCTTTTTC-3'.
###end p 31
###begin p 32
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
The target sequences for the Par-4 gene are underlined. Sense and antisense strands were annealed and ligated into linearized psiSTRIKE Vector following the manufacturer's directions. Sequence analysis of transformed randomly picked clones was used to confirm sequence integrity of Par-4 siRNA plasmids. Cells were transfected with siRNA or the indicated constructs using Lipofectamine 2000 in Opti-MEM I for 24 h, and then the medium was changed back to growth medium for additional incubation. Green fluorescent protein phMGFP vector was cotransfected to determine transfection efficiency with flow cytometry assay. Forty-eight hours after transfection, total RNA was prepared and used to perform real time quantitative PCR analysis. The level of target RNA suppression in transfected cells were determined by normalizing for transfection efficiency. Small interfering RNA-based experiment for Smac and E2F1 were similarly performed.
###end p 32
###begin title 33
RT-PCR analysis
###end title 33
###begin p 34
###xml 580 584 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 960 964 940 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</sub>
###xml 959 964 939 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A<sub>Smac</sub></italic>
###xml 965 966 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 966 976 946 956 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">beta-actin</sub>
###xml 339 345 <span type="species:ncbi:10090">murine</span>
Cells were harvested, and total RNA extraction was performed. RNA purity (A260/A280 >1.6) was checked by a spectrophotometer (GeneQuant, Type II; Pharmacia, Uppsala, Sweden), and RNA integrity was confirmed by visualization of 28 and 18 s bands (2:1) on 1% agarose gel. Subsequently, 1 mug of RNA was reverse transcribed using the Moloney-murine leukaemia virus reverse transcription system. The beta-actin was used as internal controls. PCR reactions were performed in a 50 mul mixture containing 10 x PCR buffer, MgCl2, dNTP, and Taq DNA polymerase. Amplification protocols for Smac and beta-actin consisted of 30 repetitive cycles of pre-denaturing at 95degreesC for 4 min, denaturing at 94degreesC for 30 s and annealing at 60degreesC for 60 s. Amplified cDNA was separated by 2% agarose gel electrophoresis and visualized with ethidium bromide. Semiquantitative analysis was performed using UVP-gel densitometry (San Gabriel, CA, USA). Arbitrary unit = (ASmac/Abeta-actin)x100%.
###end p 34
###begin title 35
Real time quantitative PCR
###end title 35
###begin p 36
###xml 414 419 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 475 480 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1060 1065 1035 1040 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1141 1146 1116 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1249 1254 1224 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1281 1286 1256 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1325 1336 1300 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;</sup>
###xml 1336 1338 1303 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</sup>
###xml 1336 1338 1303 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>Ct</sup></italic>
###xml 1351 1353 1314 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1358 1363 1321 1326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</sub>
###xml 1358 1363 1321 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>Par-4</sub></italic>
###xml 1367 1372 1330 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</sub>
###xml 1388 1390 1343 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1403 1405 1350 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1405 1412 1352 1359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">control</sub>
###xml 1421 1426 1364 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</sub>
###xml 1419 1426 1362 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct<sub>Par-4</sub></italic>
###xml 1426 1440 1369 1383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-siRNA-1,2,3,4</sub>
###xml 1473 1477 1416 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
Total RNA extraction was performed using TriZol reagent followed by chloroform-isopropanol extraction and ethanol precipitation. Subsequently, duplicate samples of 1 mul of each cDNA were used as a template. Real time quantitative PCR was performed using the ABI PRISM 7700 sequence detection system (PE Applied Biosystems, Wellesley, MA, USA). We used primers and a probe generated by the program Primer Premier. Par-4 primers were F (forward) 5-GCCGCAGAGTGCTTAGATGAG-3 and Par-4 R (reverse) 5-GCAGATAGGAACTGCCTGGATC-3 (fragment length, 136 bp). TaqMan probe (FAM-labelled 5-ACGAAGATGATGAAGCAGGGCAGAAAGAG-3) was added to the PCR mixture to a final concentration of 200 nM. GAPDH primers were F (forward) 5-GAAGGTGAAGGTCGGAGTC-3 and GAPDH R (reverse) 5-GAAGATGGTGATGGGATTC-3 and GAPDH TaqMan probe fluorescence labeled 5F 5-CAAGCTTCCCGTTCTCAGCC-3 were used as internal controls. Amplification conditions were as follows: 50degreesC for 2 min, 95degreesC for 10 min and then 40 cycles at 95degreesC for 15 s and 60degreesC for 60 s. GAPDH was co-amplified with Par-4. Average threshold cycle (Ct) values from the triplicate PCR reactions for Par-4 were normalized against the average Ct values for GAPDH from the same cDNA sample. The fold change of Par-4 transcript levels between Par-4-siRNA-1,2,3,4 and the control equals 2-DeltaDeltaCt, where DeltaCt = CtPar-4-Ct GAPDH, and DeltaDeltaCt = DeltaDeltaCtcontrol- DeltaCtPar-4-siRNA-1,2,3,4. Real time quantitative PCR for Smac was similarly performed.
###end p 36
###begin title 37
Construction of expression plasmids and transient transfection
###end title 37
###begin p 38
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 360 376 360 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 667 672 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 805 810 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 886 891 882 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 967 972 963 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 240 247 <span type="species:ncbi:9606">Peoples</span>
###xml 360 376 <span type="species:ncbi:562">Escherichia coli</span>
To construct and clone the eukaryotic expression vector of human Par-4, full-length cDNA of Par-4 was amplified by Rt-PCR from human neuroblastoma cell line SK-N-SH (Shanghai Institute of Cell Biology, Chinese Academy of Science, Shanghai, Peoples' Republic of China). After Rt-PCR amplification, Par-4 cDNA was inserted to plasmid pGEM-T and transformed into Escherichia coli JM109. Positive clones were amplified, screened and identified by sequencing. Then Par-4 cDNA was subcloned into pcDNA3.1 vector between the restriction enzyme sites HindIII and XhoI to generate the pcDNA3.1-Par-4 construct. For construction of pcDNA3.1-myc-Par-4, which coded a myc-tagged Par-4, Rt-PCR amplification was performed with another pair of primers, from which the stop codon of Par-4 was removed. pcDNA3.1-myc-DeltaPar-4 was similarly constructed, which encoded a myc fusion protein containing a Par-4 deletion mutant, the latter lacking 70 amino acids at the COOH terminus of Par-4. Transfections were performed using the Lipofectamine 2000 procedure following the manufacturer's protocol. Green fluorescent protein phMGFP vector was cotransfected to determine transfection efficiency with flow cytometry assay.
###end p 38
###begin title 39
Northern blotting analysis
###end title 39
###begin p 40
###xml 319 323 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 353 355 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 313 318 <span type="species:ncbi:9606">human</span>
Samples of total RNA (10 microg) were separated by electrophoresis through denaturing 1.2% agarose gels containing 1% formaldehyde and transferred onto nylon or nitrocellulose membranes using standard molecular biological techniques. Probes were derived from PCR products amplified with gene-specific primers for human Smac cDNA and labeled with [alpha-32P]dCTP using the Prime-It random priming kit (Stratagene, La Jolla, CA). Filters were reprobed with the cDNA for GAPDH to correct for the amount of RNA loaded onto the filters. Pre-hybridization and hybridization were performed at 62degreesC for 1 h and overnight, respectively. The blot was subjected to low and high stringency washes using the buffers provided in the NorthernMaxTM kit for Northern blots (Ambion Inc., Inc., Austin, TX). After hybridization, the membranes were washed and exposed at -70degreesC to X-ray film using an intensifying screen.
###end p 40
###begin title 41
Immunoprecipitations
###end title 41
###begin p 42
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 450 455 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Cells were lysed in icecold immunoprecipitation buffer (20 mM Tris-Cl (pH 7.5), 150 mM NaCl, 10% glycerol, 0.2% Nonidet P-40, and a protease inhibitor mixture (Roche Applied Science, Indianapolis, IN, USA). Lysis with immunoprecipitation buffer was complemented with sonication (5 pulses) on ice. The lysate was cleared of cell debris by centrifugation at 16 000g at 4degreesC for 30 min. The supernatant was saved for immunoprecipitation using anti-Par-4 or anti-E2F1 conjugated to Sepharose beads overnight at 4degreesC with gentle agitation. The beads were washed 3 times in lysis buffer, resuspended in 2 x Laemmli buffer and boiled for 5 min to release bound proteins. Proteins were analysed by SDS-PAGE and immunoblotting after transfer to polyvinylidene difluoride membranes.
###end p 42
###begin title 43
Isolation of nuclear proteins binding to biotinylated probes
###end title 43
###begin p 44
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 818 823 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1132 1137 1118 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1171 1176 1157 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Nuclear proteins binding to biotinylated probes were isolated as described previously (28). Briefly, oligonucleotides representing E2F1-binding site on Smac promoter sequence were synthesized, and 5 microg of the sense strand was 3'-labelled using the terminal deoxynucleotidyltransferase and biotin-14-dATP. The biotin-labelled sense strand was annealed to its complementary antisense strand and purified over a Sephadex column. The concentration of purified oligonucleotide was measured by absorbance at 260 nm, and equal amounts of annealed oligonucleotide were incubated with streptavidin-coated magnetic beads (Promega) for 30 min at room temperature. Coupling of the oligonucleotides to the beads was measured by absorbance. For the binding reaction, 50 microg of nuclear extract alone or preincubated with anti-Par-4 antibody (R334) was used. The beads were captured by a magnet, washed three times with a high salt buffer, and resuspended in Laemmli buffer. The samples were heated at 95degreesC for 5 min to elute all the proteins, loaded onto a 12% SDS-PAGE, electrophoresed, and transferred to a nitrocellulose membrane. Par-4 and E2F1 were detected using the Par-4 antibody (R334) or E2F1 antibody by immunoblotting.
###end p 44
###begin title 45
Nuclear extract preparation and electrophoretic mobility shift assays (EMSA)
###end title 45
###begin p 46
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 156 164 156 164 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGCGGAA</underline>
###xml 156 164 156 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>GCGCGGAA</underline></bold>
###xml 240 242 240 242 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</underline>
###xml 242 245 242 245 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TTA</underline>
###xml 242 245 242 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TTA</underline></bold>
###xml 245 248 245 248 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAA</underline>
###xml 300 308 300 308 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCGCGATG</underline>
###xml 370 372 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 746 748 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1363 1368 1341 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
The double-stranded oligonucleotides used for EMSA of E2F1-binding sites in Smac promoter are shown as follows: E2F1-binding BS3 site (underlined), 5'-GCCCCGCGCGGAAGTT-3'; mutated E2F1-binding BS3 site (underlined and in boldface), 5'-GCCCCGCTTAGAAGTT-3'; E2F1-binding BS2 site (underlined), 5'-GCGCAGCGCGATGCCGG-3'. The oligonucleotides were 5'-end-labeled with [gamma-32P]dATP. Nuclear proteins were extracted using a Nuclear Protein Extraction Kit. Electrophoretic mobility shift assay was performed by using a Gel Shift Assay Kit following the manufacturer's instructions. The nuclear extracts containing 30 microg of total proteins were preincubated with gel shift binding buffer for 10 min, followed by the addition of 1 microl of a [gamma-32P]-labelled, double-stranded oligonucleotide probe of E2F1 and incubation for 1h. Formed nuclear protein-DNA complexes were dissolved in 4% nondenaturing polyacrylamide gels, and electrophoresis was performed under 90 V for 2 h. Gels were dried and exposed to Kodak Biomax films at -70degreesC for 48 h. To assess the specificity of the reaction, competition assays were performed with 100-fold excess of unlabeled consensus oligonucleotide pairs of E2F1. The unlabelled probes were added to binding reaction mixture 10 min before the addition of the labelled probes. For the blocking reaction, 500 ng each of anti-Par-4 antibody (R334) and anti-E2F1 antibody were used.
###end p 46
###begin title 47
Chromatin immunoprecipitation
###end title 47
###begin p 48
###xml 186 188 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 794 799 787 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1271 1275 1258 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
hBMSCs cultured in the presence or absence of 100 muM of glutamate for 24 h were subjected to chromatin immunoprecipitation. Chromatin immunoprecipitation was done as described earlier (28). Cells were plated in a 100-mm dish. About 70% confluent dishes were treated with formaldehyde (1%) for 10 min at 37degreesC to cross-link proteins to DNA. The cells were washed twice with PBS, pH 7.4, containing protease/inhibitor mixture (Roche Applied Science) and then lysed with lysis buffer containing 1% SDS. Sonication of cross-linked chromatin was performed at 30% of maximum power with two rounds of 10 s pulses so that chromatin fragments thus obtained ranged from 500 to 2000 bp in size. Soluble chromatin was subjected to overnight immunoprecipitation with either anti-E2F1 antibody or anti-Par-4 antibody. A portion of the chromatin solution was kept to check the amount of input DNA in different samples before immunoprecipitation. Following immunoprecipitation and elution, the eluent was heated to 65degreesC for 6 h to reverse the cross-link. Phenol/chloroform extraction was performed, and the supernatant was ethanol-precipitated. DNA thus obtained was resuspended in 10 mM Tris, 1 mM EDTA, pH 8.0 and subjected to PCR. Forward and reverse primers selected for Smac promoter are as follows: sense primer, 5'-TTCCCTTCAAGCCCTGGCCCGAAC-3'; antisense primer, 5'-ACGCCCCCACCCAAGGAAGCAGTC-3'; PCR products were resolved on a 1.5% agarose gel and stained with ethidium bromide.
###end p 48
###begin title 49
Luciferase assays
###end title 49
###begin p 50
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 512 517 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 610 617 606 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 763 770 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 933 940 929 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 650 653 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
pGL3-Smac-P-Luc reporter was constructed as described previously (28). Briefly, the Smac promoter fragment (-600 to -100 bp), which contained E2F1-binding BS3 site, was cloned into the Xho I/Hind III site of pGL3-Basic plasmid with the primer pairs indicated below. Sense, 5'-CCGCTCGAGCCGTCCGCCCCTCTGGGACGGCGC-3'; Antisense, 5'-CGCAAGCTTAGCAGTCGGGATTGGGCAGGC-3'. hBMSCs were transiently cotransfected with appropriate pGL3-Smac-P-Luc reporter plasmids (200 ng) and either pcDNA3.1-myc-Par-4 or pcDNA3.1-myc-DeltaPar-4 (200 ng) using Lipofectamine 2000. In each transfection, cells were also cotransfected with Renilla luciferase reporter plasmid pRL-CMV, which served as an internal control for transfection efficiency. Cell extracts were assayed for firefly and Renilla luciferase activity. Fold-activation values were measured relative to the levels of luciferase activity in cells transfected with empty vectors and normalized by Renilla luciferase activities.
###end p 50
###begin title 51
RESULTS
###end title 51
###begin title 52
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4 played an important role in glutamate-induced hBMSCs apoptosis
###end title 52
###begin p 53
###xml 292 300 289 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 411 419 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 498 506 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 792 801 787 796 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1281 1282 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1292 1293 1282 1283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1504 1505 1493 1494 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1540 1545 1529 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1643 1648 1632 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1742 1747 1731 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1823 1824 1812 1813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1889 1890 1878 1879 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1967 1972 1956 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2015 2020 2004 2009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2152 2157 2141 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2270 2275 2259 2264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2298 2299 2287 2288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2325 2326 2314 2315 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2336 2341 2325 2330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2447 2452 2436 2441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2769 2770 2755 2756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2870 2871 2856 2857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 2871 2872 2857 2858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2970 2971 2956 2957 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 2991 2996 2977 2982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 3104 3109 3090 3095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 3291 3292 3276 3277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3394 3395 3379 3380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 3395 3396 3380 3381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 801 3494 796 3479 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">Par-4 plays an important role in glutamate-induced apoptosis of hBMSCs. (A) Glutamate induced apoptosis in hBMSCs. hBMSCs were harvested after treatment with or without 1&#8211;100 &#956;M glutamate for 6, 12 or 24 h. Cells were incubated with Annexin V-FITC and propidium iodide and analysed by flow cytometry. The percentages of apoptotic cells are presented in the bar graph. Results are means of triplicates and representative for results of three independent experiments. *, #, &#916;, <italic>P</italic> &lt; 0.05. (<bold>B</bold>) DNA Fragmentation assay in apoptotic hBMSCs. hBMSCs were harvested after treatment with (lane 1) or without (lane 2) 100 &#956;M glutamate for 24 h. DNA were precipitated and electrophoresed in 1.5% agarose gel. (<bold>C</bold>) Glutamate induced an increase of <italic>Par-4</italic> expression in hBMSCs in a dose-dependent manner. Western blotting analysis was used to determine <italic>Par-4</italic> expression in nuclear extracts in hBMSCs exposed to various doses of glutamate. Intensity of <italic>Par-4</italic> band from Western blotting were quantified and normalized with Lamin A/C. *<italic>P</italic> &lt; 0.05, compared to the hBMSCs without treatment of glutamate. (<bold>D</bold>) Real time Quantitative PCR assays for inhibitory effect of siRNA targeting <italic>Par-4</italic> gene. hBMSCs were transfected with either <italic>Par-4</italic> siRNA-1,2,3,4, scrambled siRNA or mock. Empty vector was transfected as a control. After 48 h of transfection, relative amounts of <italic>Par-4</italic> mRNA were measured by real-time quantitative RT&#8211;PCR and normalized against GAPDH. Bars depict the percentage of <italic>Par-4</italic> mRNA versus control. *<italic>P</italic> &lt; 0.05, versus control. (<bold>E</bold>) Reduced <italic>Par-4</italic> expression by siRNA inhibited glutamate-induced apoptosis of hBMSCs. hBMSCs were transfected with either <italic>Par-4</italic>-siRNA-1, scrambled siRNA or mock. After 48 h of transfection, hBMSCs were harvested in the presence or absence of 100 &#956;M glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. The result is presented in the bar graph. Values are mean &#177; SE of five independent experiments. *<italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty vector but without exposure of glutamate. <sup>#</sup><italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty vector and with exposure of glutamate. (<bold>F</bold>) Overexpression of <italic>Par-4</italic> predisposed hBMSCs to undergo apoptosis induced by glutamate. hBMSCs were transfected with either pcDNA3.1-<italic>Par-4</italic> or empty vector pcDNA3.1. After 48 h of transfection, hBMSCs were exposed to 100 &#956;M glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. *<italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty pcDNA3.1 but without exposure of glutamate. <sup>#</sup><italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty pcDNA3.1 and with exposure of glutamate.</p>
###xml 801 3494 796 3479 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54">Par-4 plays an important role in glutamate-induced apoptosis of hBMSCs. (A) Glutamate induced apoptosis in hBMSCs. hBMSCs were harvested after treatment with or without 1&#8211;100 &#956;M glutamate for 6, 12 or 24 h. Cells were incubated with Annexin V-FITC and propidium iodide and analysed by flow cytometry. The percentages of apoptotic cells are presented in the bar graph. Results are means of triplicates and representative for results of three independent experiments. *, #, &#916;, <italic>P</italic> &lt; 0.05. (<bold>B</bold>) DNA Fragmentation assay in apoptotic hBMSCs. hBMSCs were harvested after treatment with (lane 1) or without (lane 2) 100 &#956;M glutamate for 24 h. DNA were precipitated and electrophoresed in 1.5% agarose gel. (<bold>C</bold>) Glutamate induced an increase of <italic>Par-4</italic> expression in hBMSCs in a dose-dependent manner. Western blotting analysis was used to determine <italic>Par-4</italic> expression in nuclear extracts in hBMSCs exposed to various doses of glutamate. Intensity of <italic>Par-4</italic> band from Western blotting were quantified and normalized with Lamin A/C. *<italic>P</italic> &lt; 0.05, compared to the hBMSCs without treatment of glutamate. (<bold>D</bold>) Real time Quantitative PCR assays for inhibitory effect of siRNA targeting <italic>Par-4</italic> gene. hBMSCs were transfected with either <italic>Par-4</italic> siRNA-1,2,3,4, scrambled siRNA or mock. Empty vector was transfected as a control. After 48 h of transfection, relative amounts of <italic>Par-4</italic> mRNA were measured by real-time quantitative RT&#8211;PCR and normalized against GAPDH. Bars depict the percentage of <italic>Par-4</italic> mRNA versus control. *<italic>P</italic> &lt; 0.05, versus control. (<bold>E</bold>) Reduced <italic>Par-4</italic> expression by siRNA inhibited glutamate-induced apoptosis of hBMSCs. hBMSCs were transfected with either <italic>Par-4</italic>-siRNA-1, scrambled siRNA or mock. After 48 h of transfection, hBMSCs were harvested in the presence or absence of 100 &#956;M glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. The result is presented in the bar graph. Values are mean &#177; SE of five independent experiments. *<italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty vector but without exposure of glutamate. <sup>#</sup><italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty vector and with exposure of glutamate. (<bold>F</bold>) Overexpression of <italic>Par-4</italic> predisposed hBMSCs to undergo apoptosis induced by glutamate. hBMSCs were transfected with either pcDNA3.1-<italic>Par-4</italic> or empty vector pcDNA3.1. After 48 h of transfection, hBMSCs were exposed to 100 &#956;M glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. *<italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty pcDNA3.1 but without exposure of glutamate. <sup>#</sup><italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty pcDNA3.1 and with exposure of glutamate.</p></caption>
###xml 3494 3494 3479 3479 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f1"/>
###xml 792 3494 787 3479 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="54">Par-4 plays an important role in glutamate-induced apoptosis of hBMSCs. (A) Glutamate induced apoptosis in hBMSCs. hBMSCs were harvested after treatment with or without 1&#8211;100 &#956;M glutamate for 6, 12 or 24 h. Cells were incubated with Annexin V-FITC and propidium iodide and analysed by flow cytometry. The percentages of apoptotic cells are presented in the bar graph. Results are means of triplicates and representative for results of three independent experiments. *, #, &#916;, <italic>P</italic> &lt; 0.05. (<bold>B</bold>) DNA Fragmentation assay in apoptotic hBMSCs. hBMSCs were harvested after treatment with (lane 1) or without (lane 2) 100 &#956;M glutamate for 24 h. DNA were precipitated and electrophoresed in 1.5% agarose gel. (<bold>C</bold>) Glutamate induced an increase of <italic>Par-4</italic> expression in hBMSCs in a dose-dependent manner. Western blotting analysis was used to determine <italic>Par-4</italic> expression in nuclear extracts in hBMSCs exposed to various doses of glutamate. Intensity of <italic>Par-4</italic> band from Western blotting were quantified and normalized with Lamin A/C. *<italic>P</italic> &lt; 0.05, compared to the hBMSCs without treatment of glutamate. (<bold>D</bold>) Real time Quantitative PCR assays for inhibitory effect of siRNA targeting <italic>Par-4</italic> gene. hBMSCs were transfected with either <italic>Par-4</italic> siRNA-1,2,3,4, scrambled siRNA or mock. Empty vector was transfected as a control. After 48 h of transfection, relative amounts of <italic>Par-4</italic> mRNA were measured by real-time quantitative RT&#8211;PCR and normalized against GAPDH. Bars depict the percentage of <italic>Par-4</italic> mRNA versus control. *<italic>P</italic> &lt; 0.05, versus control. (<bold>E</bold>) Reduced <italic>Par-4</italic> expression by siRNA inhibited glutamate-induced apoptosis of hBMSCs. hBMSCs were transfected with either <italic>Par-4</italic>-siRNA-1, scrambled siRNA or mock. After 48 h of transfection, hBMSCs were harvested in the presence or absence of 100 &#956;M glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. The result is presented in the bar graph. Values are mean &#177; SE of five independent experiments. *<italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty vector but without exposure of glutamate. <sup>#</sup><italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty vector and with exposure of glutamate. (<bold>F</bold>) Overexpression of <italic>Par-4</italic> predisposed hBMSCs to undergo apoptosis induced by glutamate. hBMSCs were transfected with either pcDNA3.1-<italic>Par-4</italic> or empty vector pcDNA3.1. After 48 h of transfection, hBMSCs were exposed to 100 &#956;M glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. *<italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty pcDNA3.1 but without exposure of glutamate. <sup>#</sup><italic>P</italic> &lt; 0.05, compared to the cells with transfection of empty pcDNA3.1 and with exposure of glutamate.</p></caption><graphic xlink:href="gkn426f1"/></fig>
We investigated whether glutamate could induce apoptosis in hBMSCs. The cells were exposed continuously to 1-100 muM glutamate with different time lengths. Upon FACS analysis, we found that glutamate induced a dose-dependent apoptosis in hBMSCs, which started at 1 muM and peaked at 100 muM (Figure 1A), and glutamate at 100 muM induced a time-dependent cells apoptosis starting at 6 h and culminating at 24 h (Figure 1A and ), which was confirmed by the following DNA laddering assay. As shown in Figure 1B, after exposure to 100 muM glutamate for 24 h, nucleosomal DNA fragmentation, an end stage apoptotic event, was observed in hBMSCs. By contrast, no DNA laddering was found in the cells without treatment of glutamate. These data showed that glutamate could induce apoptosis in hBMSCs. Figure 1.Par-4 plays an important role in glutamate-induced apoptosis of hBMSCs. (A) Glutamate induced apoptosis in hBMSCs. hBMSCs were harvested after treatment with or without 1-100 muM glutamate for 6, 12 or 24 h. Cells were incubated with Annexin V-FITC and propidium iodide and analysed by flow cytometry. The percentages of apoptotic cells are presented in the bar graph. Results are means of triplicates and representative for results of three independent experiments. *, #, Delta, P < 0.05. (B) DNA Fragmentation assay in apoptotic hBMSCs. hBMSCs were harvested after treatment with (lane 1) or without (lane 2) 100 muM glutamate for 24 h. DNA were precipitated and electrophoresed in 1.5% agarose gel. (C) Glutamate induced an increase of Par-4 expression in hBMSCs in a dose-dependent manner. Western blotting analysis was used to determine Par-4 expression in nuclear extracts in hBMSCs exposed to various doses of glutamate. Intensity of Par-4 band from Western blotting were quantified and normalized with Lamin A/C. *P < 0.05, compared to the hBMSCs without treatment of glutamate. (D) Real time Quantitative PCR assays for inhibitory effect of siRNA targeting Par-4 gene. hBMSCs were transfected with either Par-4 siRNA-1,2,3,4, scrambled siRNA or mock. Empty vector was transfected as a control. After 48 h of transfection, relative amounts of Par-4 mRNA were measured by real-time quantitative RT-PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus control. *P < 0.05, versus control. (E) Reduced Par-4 expression by siRNA inhibited glutamate-induced apoptosis of hBMSCs. hBMSCs were transfected with either Par-4-siRNA-1, scrambled siRNA or mock. After 48 h of transfection, hBMSCs were harvested in the presence or absence of 100 muM glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. The result is presented in the bar graph. Values are mean +/- SE of five independent experiments. *P < 0.05, compared to the cells with transfection of empty vector but without exposure of glutamate. #P < 0.05, compared to the cells with transfection of empty vector and with exposure of glutamate. (F) Overexpression of Par-4 predisposed hBMSCs to undergo apoptosis induced by glutamate. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty vector pcDNA3.1. After 48 h of transfection, hBMSCs were exposed to 100 muM glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. *P < 0.05, compared to the cells with transfection of empty pcDNA3.1 but without exposure of glutamate. #P < 0.05, compared to the cells with transfection of empty pcDNA3.1 and with exposure of glutamate.
###end p 53
###begin p 54
###xml 480 481 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 491 492 486 487 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 703 704 697 698 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 739 744 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 842 847 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 941 946 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1022 1023 1016 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1088 1089 1082 1083 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1166 1171 1160 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1214 1219 1208 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1351 1356 1345 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1469 1474 1463 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1497 1498 1491 1492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1524 1525 1518 1519 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1535 1540 1529 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1646 1651 1640 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1968 1969 1959 1960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2069 2070 2060 2061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 2070 2071 2061 2062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2169 2170 2160 2161 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 2190 2195 2181 2186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2303 2308 2294 2299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2490 2491 2480 2481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2593 2594 2583 2584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 2594 2595 2584 2585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Par-4 plays an important role in glutamate-induced apoptosis of hBMSCs. (A) Glutamate induced apoptosis in hBMSCs. hBMSCs were harvested after treatment with or without 1-100 muM glutamate for 6, 12 or 24 h. Cells were incubated with Annexin V-FITC and propidium iodide and analysed by flow cytometry. The percentages of apoptotic cells are presented in the bar graph. Results are means of triplicates and representative for results of three independent experiments. *, #, Delta, P < 0.05. (B) DNA Fragmentation assay in apoptotic hBMSCs. hBMSCs were harvested after treatment with (lane 1) or without (lane 2) 100 muM glutamate for 24 h. DNA were precipitated and electrophoresed in 1.5% agarose gel. (C) Glutamate induced an increase of Par-4 expression in hBMSCs in a dose-dependent manner. Western blotting analysis was used to determine Par-4 expression in nuclear extracts in hBMSCs exposed to various doses of glutamate. Intensity of Par-4 band from Western blotting were quantified and normalized with Lamin A/C. *P < 0.05, compared to the hBMSCs without treatment of glutamate. (D) Real time Quantitative PCR assays for inhibitory effect of siRNA targeting Par-4 gene. hBMSCs were transfected with either Par-4 siRNA-1,2,3,4, scrambled siRNA or mock. Empty vector was transfected as a control. After 48 h of transfection, relative amounts of Par-4 mRNA were measured by real-time quantitative RT-PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus control. *P < 0.05, versus control. (E) Reduced Par-4 expression by siRNA inhibited glutamate-induced apoptosis of hBMSCs. hBMSCs were transfected with either Par-4-siRNA-1, scrambled siRNA or mock. After 48 h of transfection, hBMSCs were harvested in the presence or absence of 100 muM glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. The result is presented in the bar graph. Values are mean +/- SE of five independent experiments. *P < 0.05, compared to the cells with transfection of empty vector but without exposure of glutamate. #P < 0.05, compared to the cells with transfection of empty vector and with exposure of glutamate. (F) Overexpression of Par-4 predisposed hBMSCs to undergo apoptosis induced by glutamate. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty vector pcDNA3.1. After 48 h of transfection, hBMSCs were exposed to 100 muM glutamate for 24 h. The percentages of apoptosis in the cells were analysed by flow cytometry. *P < 0.05, compared to the cells with transfection of empty pcDNA3.1 but without exposure of glutamate. #P < 0.05, compared to the cells with transfection of empty pcDNA3.1 and with exposure of glutamate.
###end p 54
###begin p 55
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 139 144 139 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 364 372 364 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
To examine whether Par-4 was involved in the regulation of glutamate-induced apoptosis in hBMSCs, Western blotting was performed to detect Par-4 expression in the cells treated with or without glutamate. Because the pro-apoptotic function of Par-4 was attributed to its nuclear translocation (13), Western blotting was performed with nuclear extracts. As shown in Figure 1C, glutamate induced a dose-dependent increase of Par-4 expression in hBMSCs as compared with control.
###end p 55
###begin p 56
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 210 215 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 391 399 391 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 407 412 407 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 480 485 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 707 712 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 782 790 781 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 840 845 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 905 913 904 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 953 958 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
To further confirm the role of Par-4 in glutamate-induced apoptosis, we studied the effect of reducing Par-4 expression on apoptosis of hBMSCs after treatment with glutamate. hBMSCs was transfected with either Par-4 specific siRNA, scrambled siRNA, or no siRNA (Mock). The mRNA expression levels of Par-4 in transected cells were assessed by real time quantitative PCR analysis. As shown in Figure 1D and , Par-4-siRNA-1, one of the tested siRNA, caused an effective reduction of Par-4 mRNA. In all, 93% of Par-4 mRNA was suppressed by Par-4-siRNA-1. Then, the transfected hBMSCs were treated with or without equal concentration of glutamate (100 muM) for 24 h. FACS analysis showed that the suppression of Par-4 expression significantly attenuated the glutamate-induced apoptosis (Figure 1E and ). By contrast, transient overexpression of Par-4 increased the apoptosis cells in glutamate-treated hBMSCs (Figure 1F). Together, these data indicated that Par-4 played an important role in glutamate-induced hBMSCs apoptosis.
###end p 56
###begin title 57
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
Ectopic expression of Par-4 enhanced the expression of Smac, which could be abrogated by blocking endogenous E2F1
###end title 57
###begin p 58
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 313 322 313 322 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 474 475 474 475 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1233 1234 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1292 1293 1286 1287 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1994 1995 1986 1987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2052 2053 2044 2045 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2641 2642 2631 2632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2699 2700 2689 2690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3617 3618 3605 3606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3679 3680 3667 3668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3741 3742 3729 3730 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 4264 4265 4250 4251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 4334 4335 4320 4321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 4335 4336 4321 4322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 4388 4393 4374 4379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 322 4394 322 4380 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">Ectopic expression of Par-4 enhanced Smac protein and transcript. Blocking endogenous E2F1 abrogated the enhancement of Par-4-induced Smac expression. (<bold>A</bold>) Glutamate induced a release of Smac from mitochondria. hBMSCs were treated with glutamate at the dose from 1 to 100 &#181;M. Subcellular localization of Smac was determined by western blotting after 24 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantified. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are mean &#177; S.E. of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells without treatment of glutamate. (<bold>B</bold>) Overexpression of Par-4 enhanced Smac protein in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. Subcellular localization of Smac was determined by Western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean &#177; SE of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells transfected with empty vector. (<bold>C</bold>) Overexpression of Par-4 enhanced Smac transcript in hBMSCs. Northern blotting was used to determine Smac mRNA in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. After 24 h of transfection, total cellular RNAs were separated and hybridized to 32P-labelled DNA probes. GAPDH probe was used to normalize for differences in RNA loading. Intensities of bands from northern blotting analysis were quantitated and normalized with GAPDH. Arbitrary unit = (ASmac/AGAPDH)&#215;100%. Values are mean &#177; SE of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells transfected with empty vector. (<bold>D</bold>) Blocking endogenous E2F1 by siRNA abrogated the enhancement of Par-4-induced Smac protein in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As controls, these plasmids or empty vectors were respectively transfected into hBMSCs. Subcellular localization of Smac/DIABLO was determined by western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin protein was analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantitated. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean &#177; S.E. of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus untransfected cells (the first bar at left). *<italic>P</italic> &lt; 0.05 versus hBMSCs transfected only with pcDNA3.1-Par-4. (<bold>E</bold>) Blocking endogenous E2F1 by siRNA abrogated enhancement of Par-4-induced Smac transcript in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As a control, empty vector was respectively transfected into hBMSCs. After 24 h of transfection, relative amount of Par-4 mRNA was measured by real-time quantitative RT&#8211;PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus that of untransfected cells. Values are mean &#177; SE of three independent experiments. *<italic>P</italic> &lt; 0.05 versus untransfected cells (control, the first bar at left). <sup>#</sup><italic>P</italic> &lt; 0.05 versus transfected cells only with pcDNA3.1-<italic>Par-4</italic>.</p>
###xml 322 4394 322 4380 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="59">Ectopic expression of Par-4 enhanced Smac protein and transcript. Blocking endogenous E2F1 abrogated the enhancement of Par-4-induced Smac expression. (<bold>A</bold>) Glutamate induced a release of Smac from mitochondria. hBMSCs were treated with glutamate at the dose from 1 to 100 &#181;M. Subcellular localization of Smac was determined by western blotting after 24 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantified. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are mean &#177; S.E. of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells without treatment of glutamate. (<bold>B</bold>) Overexpression of Par-4 enhanced Smac protein in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. Subcellular localization of Smac was determined by Western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean &#177; SE of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells transfected with empty vector. (<bold>C</bold>) Overexpression of Par-4 enhanced Smac transcript in hBMSCs. Northern blotting was used to determine Smac mRNA in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. After 24 h of transfection, total cellular RNAs were separated and hybridized to 32P-labelled DNA probes. GAPDH probe was used to normalize for differences in RNA loading. Intensities of bands from northern blotting analysis were quantitated and normalized with GAPDH. Arbitrary unit = (ASmac/AGAPDH)&#215;100%. Values are mean &#177; SE of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells transfected with empty vector. (<bold>D</bold>) Blocking endogenous E2F1 by siRNA abrogated the enhancement of Par-4-induced Smac protein in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As controls, these plasmids or empty vectors were respectively transfected into hBMSCs. Subcellular localization of Smac/DIABLO was determined by western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin protein was analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantitated. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean &#177; S.E. of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus untransfected cells (the first bar at left). *<italic>P</italic> &lt; 0.05 versus hBMSCs transfected only with pcDNA3.1-Par-4. (<bold>E</bold>) Blocking endogenous E2F1 by siRNA abrogated enhancement of Par-4-induced Smac transcript in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As a control, empty vector was respectively transfected into hBMSCs. After 24 h of transfection, relative amount of Par-4 mRNA was measured by real-time quantitative RT&#8211;PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus that of untransfected cells. Values are mean &#177; SE of three independent experiments. *<italic>P</italic> &lt; 0.05 versus untransfected cells (control, the first bar at left). <sup>#</sup><italic>P</italic> &lt; 0.05 versus transfected cells only with pcDNA3.1-<italic>Par-4</italic>.</p></caption>
###xml 4394 4394 4380 4380 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f2a"/>
###xml 4394 4394 4380 4380 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f2b"/>
###xml 313 4394 313 4380 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="59">Ectopic expression of Par-4 enhanced Smac protein and transcript. Blocking endogenous E2F1 abrogated the enhancement of Par-4-induced Smac expression. (<bold>A</bold>) Glutamate induced a release of Smac from mitochondria. hBMSCs were treated with glutamate at the dose from 1 to 100 &#181;M. Subcellular localization of Smac was determined by western blotting after 24 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantified. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are mean &#177; S.E. of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells without treatment of glutamate. (<bold>B</bold>) Overexpression of Par-4 enhanced Smac protein in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. Subcellular localization of Smac was determined by Western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean &#177; SE of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells transfected with empty vector. (<bold>C</bold>) Overexpression of Par-4 enhanced Smac transcript in hBMSCs. Northern blotting was used to determine Smac mRNA in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. After 24 h of transfection, total cellular RNAs were separated and hybridized to 32P-labelled DNA probes. GAPDH probe was used to normalize for differences in RNA loading. Intensities of bands from northern blotting analysis were quantitated and normalized with GAPDH. Arbitrary unit = (ASmac/AGAPDH)&#215;100%. Values are mean &#177; SE of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus the cells transfected with empty vector. (<bold>D</bold>) Blocking endogenous E2F1 by siRNA abrogated the enhancement of Par-4-induced Smac protein in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As controls, these plasmids or empty vectors were respectively transfected into hBMSCs. Subcellular localization of Smac/DIABLO was determined by western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin protein was analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantitated. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean &#177; S.E. of three independent experiments performed in duplicate. *<italic>P</italic> &lt; 0.05 versus untransfected cells (the first bar at left). *<italic>P</italic> &lt; 0.05 versus hBMSCs transfected only with pcDNA3.1-Par-4. (<bold>E</bold>) Blocking endogenous E2F1 by siRNA abrogated enhancement of Par-4-induced Smac transcript in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As a control, empty vector was respectively transfected into hBMSCs. After 24 h of transfection, relative amount of Par-4 mRNA was measured by real-time quantitative RT&#8211;PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus that of untransfected cells. Values are mean &#177; SE of three independent experiments. *<italic>P</italic> &lt; 0.05 versus untransfected cells (control, the first bar at left). <sup>#</sup><italic>P</italic> &lt; 0.05 versus transfected cells only with pcDNA3.1-<italic>Par-4</italic>.</p></caption><graphic xlink:href="gkn426f2a"/><graphic xlink:href="gkn426f2b"/></fig>
To determine whether Smac is involved in glutamate-induced hBMSCs apoptosis, Western blotting was performed to detect the release of Smac from mitochondria. Figure 2A showed that Smac protein releasing from mitochondria exhibited an apparent increase upon the treatment with glutamate in a dose-dependent manner. Figure 2.Ectopic expression of Par-4 enhanced Smac protein and transcript. Blocking endogenous E2F1 abrogated the enhancement of Par-4-induced Smac expression. (A) Glutamate induced a release of Smac from mitochondria. hBMSCs were treated with glutamate at the dose from 1 to 100 microM. Subcellular localization of Smac was determined by western blotting after 24 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantified. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are mean +/- S.E. of three independent experiments performed in duplicate. *P < 0.05 versus the cells without treatment of glutamate. (B) Overexpression of Par-4 enhanced Smac protein in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. Subcellular localization of Smac was determined by Western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean +/- SE of three independent experiments performed in duplicate. *P < 0.05 versus the cells transfected with empty vector. (C) Overexpression of Par-4 enhanced Smac transcript in hBMSCs. Northern blotting was used to determine Smac mRNA in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. After 24 h of transfection, total cellular RNAs were separated and hybridized to 32P-labelled DNA probes. GAPDH probe was used to normalize for differences in RNA loading. Intensities of bands from northern blotting analysis were quantitated and normalized with GAPDH. Arbitrary unit = (ASmac/AGAPDH)x100%. Values are mean +/- SE of three independent experiments performed in duplicate. *P < 0.05 versus the cells transfected with empty vector. (D) Blocking endogenous E2F1 by siRNA abrogated the enhancement of Par-4-induced Smac protein in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As controls, these plasmids or empty vectors were respectively transfected into hBMSCs. Subcellular localization of Smac/DIABLO was determined by western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin protein was analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantitated. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean +/- S.E. of three independent experiments performed in duplicate. *P < 0.05 versus untransfected cells (the first bar at left). *P < 0.05 versus hBMSCs transfected only with pcDNA3.1-Par-4. (E) Blocking endogenous E2F1 by siRNA abrogated enhancement of Par-4-induced Smac transcript in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As a control, empty vector was respectively transfected into hBMSCs. After 24 h of transfection, relative amount of Par-4 mRNA was measured by real-time quantitative RT-PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus that of untransfected cells. Values are mean +/- SE of three independent experiments. *P < 0.05 versus untransfected cells (control, the first bar at left). #P < 0.05 versus transfected cells only with pcDNA3.1-Par-4.
###end p 58
###begin p 59
###xml 152 153 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 911 912 905 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 970 971 964 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1672 1673 1664 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1730 1731 1722 1723 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2319 2320 2309 2310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2377 2378 2367 2368 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 3295 3296 3283 3284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3357 3358 3345 3346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 3419 3420 3407 3408 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 3942 3943 3928 3929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 4012 4013 3998 3999 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 4013 4014 3999 4000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 4066 4071 4052 4057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Ectopic expression of Par-4 enhanced Smac protein and transcript. Blocking endogenous E2F1 abrogated the enhancement of Par-4-induced Smac expression. (A) Glutamate induced a release of Smac from mitochondria. hBMSCs were treated with glutamate at the dose from 1 to 100 microM. Subcellular localization of Smac was determined by western blotting after 24 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantified. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are mean +/- S.E. of three independent experiments performed in duplicate. *P < 0.05 versus the cells without treatment of glutamate. (B) Overexpression of Par-4 enhanced Smac protein in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. Subcellular localization of Smac was determined by Western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin levels were analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean +/- SE of three independent experiments performed in duplicate. *P < 0.05 versus the cells transfected with empty vector. (C) Overexpression of Par-4 enhanced Smac transcript in hBMSCs. Northern blotting was used to determine Smac mRNA in hBMSCs. hBMSCs were transfected with either pcDNA3.1-Par-4 or empty pcDNA3.1 vector. After 24 h of transfection, total cellular RNAs were separated and hybridized to 32P-labelled DNA probes. GAPDH probe was used to normalize for differences in RNA loading. Intensities of bands from northern blotting analysis were quantitated and normalized with GAPDH. Arbitrary unit = (ASmac/AGAPDH)x100%. Values are mean +/- SE of three independent experiments performed in duplicate. *P < 0.05 versus the cells transfected with empty vector. (D) Blocking endogenous E2F1 by siRNA abrogated the enhancement of Par-4-induced Smac protein in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As controls, these plasmids or empty vectors were respectively transfected into hBMSCs. Subcellular localization of Smac/DIABLO was determined by western blotting after 48 h, and protein levels were quantified by computer-assisted densitometry. Tubulin protein was analysed to confirm equal protein loading in cytosol. Hsp60 was used to monitor the absence of mitochondrial contamination in the cytosolic fraction and to verify equal protein loading in mitochondrial fraction. Intensities of bands from western blotting analysis were quantitated. Results are indicated as the ratio between Smac levels in mitochondria versus Smac levels in cytosol and are the mean +/- S.E. of three independent experiments performed in duplicate. *P < 0.05 versus untransfected cells (the first bar at left). *P < 0.05 versus hBMSCs transfected only with pcDNA3.1-Par-4. (E) Blocking endogenous E2F1 by siRNA abrogated enhancement of Par-4-induced Smac transcript in hBMSCs. hBMSCs were co-transfected with pcDNA3.1-Par-4 and psiSTRIKE-E2F1-siRNA-1 vector. As a control, empty vector was respectively transfected into hBMSCs. After 24 h of transfection, relative amount of Par-4 mRNA was measured by real-time quantitative RT-PCR and normalized against GAPDH. Bars depict the percentage of Par-4 mRNA versus that of untransfected cells. Values are mean +/- SE of three independent experiments. *P < 0.05 versus untransfected cells (control, the first bar at left). #P < 0.05 versus transfected cells only with pcDNA3.1-Par-4.
###end p 59
###begin p 60
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 319 327 319 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 491 496 491 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 527 531 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
We next examined the relationship between Par-4 and Smac. hBMSCs were transfected with plasmid pcDNA3.1-Par-4, which contained complete Par-4 CDS. The same amount of empty pcDNA3 vector was also introduced into cells as a control. Smac protein expression was found to be upmodulated in the Par-4 overexpressing hBMSCs (Figure 2B and ). Northern blotting showed that Smac transcript in hBMSCs was enhanced as well (Figure 2C), suggesting a previously undefined transcriptional mechanism that Par-4 could mediate upmodulation of Smac protein.
###end p 60
###begin p 61
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 388 396 388 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 483 488 483 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 509 513 509 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 534 542 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
To characterize the involvement of E2F1 in the regulation of Smac in hBMSCs, we blocked the expression of endogenous E2F1 protein using siRNA. hBMSCs were cotransfected with pcDNA3-Par-4 and plasmid pSiRNA-E2F1-1, the latter specifically targeting E2F1 for gene silencing. Western blotting analysis demonstrated Smac expression was restrained following the inhibition of E2F1 expression (Figure 2D and ). Real time quantitative RT-PCR showed that pSiRNA-E2F1-1 could represse pcDNA3-Par-4-induced increase of Smac mRNA transcription (Figure 2E). These data indicated that E2F1 participated in Par-4-induced Smac transcription and expression.
###end p 61
###begin title 62
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4 and E2F1 formed a protein complex in glutamate-treated hBMSCs
###end title 62
###begin p 63
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 310 315 310 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 411 416 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 536 541 536 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 552 561 552 561 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 881 886 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1227 1232 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 561 1319 561 1307 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="64">Glutamate induced the formation of protein complex containing <italic>Par-4</italic> and E2F1. Immunoprecipitations and western blotting analysis were performed with whole-cell extracts in hBMSCs with or without treatment of 100 &#181;M glutamate for 24 h. The whole-cell extracts (0.15 mg protein/0.5 ml), were mixed with 10 &#956;l of anti-<italic>Par-4</italic> antibody or preimmune serum. The mixtures were incubated at 4&#176;C for 1 h, and then 10 &#956;l protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Immunoprecipitations with E2F1 antibody and Western blotting with <italic>Par-4</italic> antibody were similarly performed. The other E2F1 family members were used as control.</p>
###xml 561 1319 561 1307 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="64">Glutamate induced the formation of protein complex containing <italic>Par-4</italic> and E2F1. Immunoprecipitations and western blotting analysis were performed with whole-cell extracts in hBMSCs with or without treatment of 100 &#181;M glutamate for 24 h. The whole-cell extracts (0.15 mg protein/0.5 ml), were mixed with 10 &#956;l of anti-<italic>Par-4</italic> antibody or preimmune serum. The mixtures were incubated at 4&#176;C for 1 h, and then 10 &#956;l protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Immunoprecipitations with E2F1 antibody and Western blotting with <italic>Par-4</italic> antibody were similarly performed. The other E2F1 family members were used as control.</p></caption>
###xml 1319 1319 1307 1307 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f3"/>
###xml 552 1319 552 1307 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="64">Glutamate induced the formation of protein complex containing <italic>Par-4</italic> and E2F1. Immunoprecipitations and western blotting analysis were performed with whole-cell extracts in hBMSCs with or without treatment of 100 &#181;M glutamate for 24 h. The whole-cell extracts (0.15 mg protein/0.5 ml), were mixed with 10 &#956;l of anti-<italic>Par-4</italic> antibody or preimmune serum. The mixtures were incubated at 4&#176;C for 1 h, and then 10 &#956;l protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Immunoprecipitations with E2F1 antibody and Western blotting with <italic>Par-4</italic> antibody were similarly performed. The other E2F1 family members were used as control.</p></caption><graphic xlink:href="gkn426f3"/></fig>
Based on the strong correlation among Par-4, E2F1 and Smac from our above study, we further characterized the interaction among these molecules. As shown in Figure 3, Par-4 co-immunoprecipitated with E2F1 protein in nuclear extracts from the glutamate-treated hBMSCs, indicating the direct interaction between Par-4 and E2F1. By contrast, in nuclear extracts from the hBMSCs without the treatment of glutamate, Par-4 failed to associate with E2F1. These data suggested that glutamate induced the formation of protein complex containing Par-4 and E2F1. Figure 3.Glutamate induced the formation of protein complex containing Par-4 and E2F1. Immunoprecipitations and western blotting analysis were performed with whole-cell extracts in hBMSCs with or without treatment of 100 microM glutamate for 24 h. The whole-cell extracts (0.15 mg protein/0.5 ml), were mixed with 10 mul of anti-Par-4 antibody or preimmune serum. The mixtures were incubated at 4degreesC for 1 h, and then 10 mul protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Immunoprecipitations with E2F1 antibody and Western blotting with Par-4 antibody were similarly performed. The other E2F1 family members were used as control.
###end p 63
###begin p 64
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 320 325 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 666 671 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Glutamate induced the formation of protein complex containing Par-4 and E2F1. Immunoprecipitations and western blotting analysis were performed with whole-cell extracts in hBMSCs with or without treatment of 100 microM glutamate for 24 h. The whole-cell extracts (0.15 mg protein/0.5 ml), were mixed with 10 mul of anti-Par-4 antibody or preimmune serum. The mixtures were incubated at 4degreesC for 1 h, and then 10 mul protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Immunoprecipitations with E2F1 antibody and Western blotting with Par-4 antibody were similarly performed. The other E2F1 family members were used as control.
###end p 64
###begin title 65
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
It was E2F1, not Par-4, which directly bound to Smac promoter in Par-4-E2F1 complex, and Par-4 exerted its transcriptional control on Smac gene through indirect interacting with E2F1
###end title 65
###begin p 66
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 711 716 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 742 747 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 780 785 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 853 861 852 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 872 880 871 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 896 901 895 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 954 956 953 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 993 998 992 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1047 1052 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1177 1181 1176 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1192 1200 1191 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1319 1327 1318 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1388 1393 1387 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1442 1446 1441 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1485 1494 1484 1493 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 1494 1499 1493 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1518 1522 1517 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1571 1572 1570 1571 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1577 1578 1576 1577 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1775 1780 1766 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1968 1972 1959 1963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 2286 2291 2271 2276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2325 2330 2310 2315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2384 2385 2369 2370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2459 2463 2444 2448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 2744 2749 2725 2730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1494 2985 1493 2966 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="67"><italic>Par-4</italic> and E2F1 bound to <italic>Smac</italic> promoter in hBMSCs with exposure of glutamate. (<bold>A</bold> and <bold>B</bold>) hBMSCs were treated with or without 100 &#181;M glutamate for 24 h. And nuclear proteins were isolated. Before the binding reaction, 50 &#181;g of nuclear extract was preincubated with either anti-<italic>Par-4</italic> antibody (R334) or anti-E2F1 antibody. Subsequently, these nuclear extracts were co-incubated with the magnetic beads containing biotinylated oligonucleotide sequence of SB3 sites within <italic>Smac</italic> promoter for binding reaction. The beads were captured by a magnet, washed three times with a high salt buffer, and resuspended in Laemmli buffer. The samples were heated at 95&#176;C for 5 min to elute all the proteins, loaded onto a 12% SDS&#8211;PAGE, electrophoresed, and transferred to a nitrocellulose membrane. <italic>Par-4</italic> and E2F1 were detected using the <italic>Par-4</italic> antibody (R334) or E2F1 antibody by immunoblotting. (<bold>C</bold>) DNA-binding activity of E2F1-binding sites BS3 (&#8722;200 to &#8722;193 bp) within <italic>Smac</italic> promoter was assessed by electrophoretic mobility shift assay. After treatment with or without 100 &#181;M glutamate for 24 h, nuclear extracts were obtained from the hBMSCs. Nuclear extracts were incubated with the probes in the presence or absence of antibodies directed against <italic>Par-4</italic> or E2F1. In competition studies, a 100-fold molar excess of unlabelled oligonucleotide was added to binding reaction mixture before the addition of the labelled probes. Results shown are representative of three independent experiments.</p>
###xml 1494 2985 1493 2966 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="67"><italic>Par-4</italic> and E2F1 bound to <italic>Smac</italic> promoter in hBMSCs with exposure of glutamate. (<bold>A</bold> and <bold>B</bold>) hBMSCs were treated with or without 100 &#181;M glutamate for 24 h. And nuclear proteins were isolated. Before the binding reaction, 50 &#181;g of nuclear extract was preincubated with either anti-<italic>Par-4</italic> antibody (R334) or anti-E2F1 antibody. Subsequently, these nuclear extracts were co-incubated with the magnetic beads containing biotinylated oligonucleotide sequence of SB3 sites within <italic>Smac</italic> promoter for binding reaction. The beads were captured by a magnet, washed three times with a high salt buffer, and resuspended in Laemmli buffer. The samples were heated at 95&#176;C for 5 min to elute all the proteins, loaded onto a 12% SDS&#8211;PAGE, electrophoresed, and transferred to a nitrocellulose membrane. <italic>Par-4</italic> and E2F1 were detected using the <italic>Par-4</italic> antibody (R334) or E2F1 antibody by immunoblotting. (<bold>C</bold>) DNA-binding activity of E2F1-binding sites BS3 (&#8722;200 to &#8722;193 bp) within <italic>Smac</italic> promoter was assessed by electrophoretic mobility shift assay. After treatment with or without 100 &#181;M glutamate for 24 h, nuclear extracts were obtained from the hBMSCs. Nuclear extracts were incubated with the probes in the presence or absence of antibodies directed against <italic>Par-4</italic> or E2F1. In competition studies, a 100-fold molar excess of unlabelled oligonucleotide was added to binding reaction mixture before the addition of the labelled probes. Results shown are representative of three independent experiments.</p></caption>
###xml 2985 2985 2966 2966 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f4"/>
###xml 1485 2985 1484 2966 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="67"><italic>Par-4</italic> and E2F1 bound to <italic>Smac</italic> promoter in hBMSCs with exposure of glutamate. (<bold>A</bold> and <bold>B</bold>) hBMSCs were treated with or without 100 &#181;M glutamate for 24 h. And nuclear proteins were isolated. Before the binding reaction, 50 &#181;g of nuclear extract was preincubated with either anti-<italic>Par-4</italic> antibody (R334) or anti-E2F1 antibody. Subsequently, these nuclear extracts were co-incubated with the magnetic beads containing biotinylated oligonucleotide sequence of SB3 sites within <italic>Smac</italic> promoter for binding reaction. The beads were captured by a magnet, washed three times with a high salt buffer, and resuspended in Laemmli buffer. The samples were heated at 95&#176;C for 5 min to elute all the proteins, loaded onto a 12% SDS&#8211;PAGE, electrophoresed, and transferred to a nitrocellulose membrane. <italic>Par-4</italic> and E2F1 were detected using the <italic>Par-4</italic> antibody (R334) or E2F1 antibody by immunoblotting. (<bold>C</bold>) DNA-binding activity of E2F1-binding sites BS3 (&#8722;200 to &#8722;193 bp) within <italic>Smac</italic> promoter was assessed by electrophoretic mobility shift assay. After treatment with or without 100 &#181;M glutamate for 24 h, nuclear extracts were obtained from the hBMSCs. Nuclear extracts were incubated with the probes in the presence or absence of antibodies directed against <italic>Par-4</italic> or E2F1. In competition studies, a 100-fold molar excess of unlabelled oligonucleotide was added to binding reaction mixture before the addition of the labelled probes. Results shown are representative of three independent experiments.</p></caption><graphic xlink:href="gkn426f4"/></fig>
Next, we used a previously identified E2F1-binding site BS3 (-200 to -193 bp relative to ATG) on the Smac promoter as bait to pull out potential interacting molecules (12). This Smac promoter sequence was labelled with biotin using terminal deoxynucleotidyltransferase and incubated with nuclear extracts from hBMSCs treated with or without 100 muM glutamate for 24 h. Following this, the samples were subjected to high salt washes to remove any non-specific binding. The washed complex was pulled out, using streptavidin conjugated to magnetic beads, with the help of a magnet. The proteins binding to the promoter were eluted by boiling in Laemmli's buffer and subjected to SDS-PAGE, and Western blotting for Par-4 was performed using anti-Par-4 antibody. Indeed, we found that Par-4 and E2F1 existed in nuclear extracts from glutamate-treated cells (Figure 4A, lane 1; Figure 4B, lane 1). The Par-4-specific antibody (R334) has been shown previously (28) to disrupt the interaction between Par-4 and other molecules. We could not almost detect Par-4 in the nuclear extracts preincubated with the R334 antibody and then incubated with the biotin-labeled E2F1-binding site on Smac promoter (Figure 4A, lane 2). Similarly, E2F1 also decreased markedly upon the pre-incubation of the neutralizing antibody against E2F1 (Figure 4B, lane 2). Together, this set of experiments indicated that Par-4 and E2F1 bound either indirectly or directly to Smac promoter in glutamate-treated hBMSCs. Figure 4.Par-4 and E2F1 bound to Smac promoter in hBMSCs with exposure of glutamate. (A and B) hBMSCs were treated with or without 100 microM glutamate for 24 h. And nuclear proteins were isolated. Before the binding reaction, 50 microg of nuclear extract was preincubated with either anti-Par-4 antibody (R334) or anti-E2F1 antibody. Subsequently, these nuclear extracts were co-incubated with the magnetic beads containing biotinylated oligonucleotide sequence of SB3 sites within Smac promoter for binding reaction. The beads were captured by a magnet, washed three times with a high salt buffer, and resuspended in Laemmli buffer. The samples were heated at 95degreesC for 5 min to elute all the proteins, loaded onto a 12% SDS-PAGE, electrophoresed, and transferred to a nitrocellulose membrane. Par-4 and E2F1 were detected using the Par-4 antibody (R334) or E2F1 antibody by immunoblotting. (C) DNA-binding activity of E2F1-binding sites BS3 (-200 to -193 bp) within Smac promoter was assessed by electrophoretic mobility shift assay. After treatment with or without 100 microM glutamate for 24 h, nuclear extracts were obtained from the hBMSCs. Nuclear extracts were incubated with the probes in the presence or absence of antibodies directed against Par-4 or E2F1. In competition studies, a 100-fold molar excess of unlabelled oligonucleotide was added to binding reaction mixture before the addition of the labelled probes. Results shown are representative of three independent experiments.
###end p 66
###begin p 67
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 281 286 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 474 478 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 792 797 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 831 836 817 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 890 891 876 877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 965 969 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1250 1255 1232 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Par-4 and E2F1 bound to Smac promoter in hBMSCs with exposure of glutamate. (A and B) hBMSCs were treated with or without 100 microM glutamate for 24 h. And nuclear proteins were isolated. Before the binding reaction, 50 microg of nuclear extract was preincubated with either anti-Par-4 antibody (R334) or anti-E2F1 antibody. Subsequently, these nuclear extracts were co-incubated with the magnetic beads containing biotinylated oligonucleotide sequence of SB3 sites within Smac promoter for binding reaction. The beads were captured by a magnet, washed three times with a high salt buffer, and resuspended in Laemmli buffer. The samples were heated at 95degreesC for 5 min to elute all the proteins, loaded onto a 12% SDS-PAGE, electrophoresed, and transferred to a nitrocellulose membrane. Par-4 and E2F1 were detected using the Par-4 antibody (R334) or E2F1 antibody by immunoblotting. (C) DNA-binding activity of E2F1-binding sites BS3 (-200 to -193 bp) within Smac promoter was assessed by electrophoretic mobility shift assay. After treatment with or without 100 microM glutamate for 24 h, nuclear extracts were obtained from the hBMSCs. Nuclear extracts were incubated with the probes in the presence or absence of antibodies directed against Par-4 or E2F1. In competition studies, a 100-fold molar excess of unlabelled oligonucleotide was added to binding reaction mixture before the addition of the labelled probes. Results shown are representative of three independent experiments.
###end p 67
###begin p 68
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 120 128 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 380 388 380 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 552 557 552 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 716 721 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 740 745 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 973 978 973 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 980 988 980 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1173 1181 1173 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1239 1244 1239 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1249 1254 1249 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1300 1304 1300 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1324 1329 1324 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1384 1388 1384 1388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1604 1612 1604 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
To further elucidate the molecular mechanisms by which Par-4 and E2F1 interact with the Smac promoter, EMSA experiments in vitro were performed with the nuclear extracts from hBMSCs treated with glutamate. Previously defined E2F1-binding site BS3 (-200 to -193 bp relative to ATG) on Smac promoter were used as probes (12). Two complexes were formed with the BS3 oligonucleotide (Figure 4C, lane 2). Competition with increasing amounts of cold competitor demonstrated that both complexes were specific (Figure 4C, lane 3). To determine the presence of Par-4 and E2F1 in the complexes formed, nuclear extracts from the glutamate-treated hBMSCs were incubated with the BS3 probe along with antibodies directed against Par-4 or E2F1. The anti-Par-4 antibody is directed against the COOH terminus of Par-4 and has been demonstrated previously as a blocking antibody (28). The anti-Par-4 antibody caused disappearance of the slower migrating complex, indicating the presence of Par-4 (Figure 4C, lane 4). The neutralizing antibody against E2F1 caused disappearance of both the faster and the slower migrating complex, thus indicating the presence of E2F1 in both the complexes (Figure 4C, lane 5). These results supported that it was E2F1, not Par-4, in Par-4-E2F1 proteins complex that directly bound to Smac promoter, and that Par-4 might indirectly exert its transcriptional control on Smac gene though interacting with E2F1. The BS3 E2F1-binding site was also used as a probe to perform EMSA with nuclear extracts from the hBMSCs without treatment of glutamate. However, no DNA-protein complex was found (Figure 4C, lane 7). Therefore, the presence of glutamate was critical for the formation of these DNA-protein complexes.
###end p 68
###begin title 69
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Par-4-E2F1 complex bound to the BS3 Site (-200 to-193 bp relative to ATG) within Smac promoter in glutamate-treated hBMSCs in vivo
###end title 69
###begin p 70
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 434 439 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 549 553 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 617 622 617 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 684 692 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 777 781 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 792 800 792 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 919 927 919 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 977 982 977 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1237 1242 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1327 1331 1327 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1378 1382 1378 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1412 1417 1412 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1537 1542 1537 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1603 1607 1603 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1617 1624 1617 1624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1654 1663 1654 1663 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 1680 1687 1680 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1699 1704 1699 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1767 1771 1767 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1772 1778 1772 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIABLO</italic>
###xml 1965 1970 1961 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2189 2193 2185 2189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1663 2484 1663 2480 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="71">Demonstration of <italic>in vivo</italic> binding of <italic>Par-4</italic> and E2F1 to BS3 site (&#8722;200 to &#8722;193 bp relative to ATG) on the <italic>Smac</italic>/<italic>DIABLO</italic> promoter by chromatin immunoprecipitation. hBMSCs were treated with or without 100 &#181;M glutamate for 24 h. Chromatin lysates were immunoprecipitated (IP) with either antibody against <italic>Par-4</italic> or antibody against E2F1. The samples were processed as described under &#8216;Materials and Methods&#8217; section. Immunoprecipitated DNA was amplified using primers representing the BS3 site (&#8722;200 to&#8722;193 bp relative to ATG) on <italic>Smac</italic> promoter. PCR analysis of the total input DNA was also preformed. Products of chromatin immunoprecipitation and PCR amplification were analysed by 2% agarose gel electrophoresis and beta-actin was performed as a negative control. Results are representative of three independent experiments.</p>
###xml 1663 2484 1663 2480 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="71">Demonstration of <italic>in vivo</italic> binding of <italic>Par-4</italic> and E2F1 to BS3 site (&#8722;200 to &#8722;193 bp relative to ATG) on the <italic>Smac</italic>/<italic>DIABLO</italic> promoter by chromatin immunoprecipitation. hBMSCs were treated with or without 100 &#181;M glutamate for 24 h. Chromatin lysates were immunoprecipitated (IP) with either antibody against <italic>Par-4</italic> or antibody against E2F1. The samples were processed as described under &#8216;Materials and Methods&#8217; section. Immunoprecipitated DNA was amplified using primers representing the BS3 site (&#8722;200 to&#8722;193 bp relative to ATG) on <italic>Smac</italic> promoter. PCR analysis of the total input DNA was also preformed. Products of chromatin immunoprecipitation and PCR amplification were analysed by 2% agarose gel electrophoresis and beta-actin was performed as a negative control. Results are representative of three independent experiments.</p></caption>
###xml 2484 2484 2480 2480 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f5"/>
###xml 1654 2484 1654 2480 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="71">Demonstration of <italic>in vivo</italic> binding of <italic>Par-4</italic> and E2F1 to BS3 site (&#8722;200 to &#8722;193 bp relative to ATG) on the <italic>Smac</italic>/<italic>DIABLO</italic> promoter by chromatin immunoprecipitation. hBMSCs were treated with or without 100 &#181;M glutamate for 24 h. Chromatin lysates were immunoprecipitated (IP) with either antibody against <italic>Par-4</italic> or antibody against E2F1. The samples were processed as described under &#8216;Materials and Methods&#8217; section. Immunoprecipitated DNA was amplified using primers representing the BS3 site (&#8722;200 to&#8722;193 bp relative to ATG) on <italic>Smac</italic> promoter. PCR analysis of the total input DNA was also preformed. Products of chromatin immunoprecipitation and PCR amplification were analysed by 2% agarose gel electrophoresis and beta-actin was performed as a negative control. Results are representative of three independent experiments.</p></caption><graphic xlink:href="gkn426f5"/></fig>
To evaluate directly the potential significance of physical interactions among Par-4, E2F1 and Smac promoter, we investigated whether Par-4 and E2F1 associate on the chromatin of endogenous Smac promoter using the chromatin immunoprecipitation assay. We immunoprecipitated chromatin from the glutamate-treated hBMSCs, using specific antibodies against Par-4 and E2F1 or no antibody at all as a control. Genomic DNA fragments bound to Par-4 or E2F1 were analysed by PCR using primers upstream of the BS3 (-200 to -193 bp relative to ATG) site within Smac promoter. Analysis of genomic DNA immunoprecipitated with anti-Par-4 antibody revealed Smac promoter in glutamate-treated hBMSCs (Figure 5, lane 4). Also, immunoprecipitates from anti-E2F1 antibody revealed the presence of Smac promoter (Figure 5, lane 5). As expected, when minus the antibodies in the immunoprecipitation procedure, no genomic DNA was pulled out (Figure 5, lane 6). Chromatin immunoprecipitated with anti-Par-4 antibody or anti-E2F1 antibody was subjected to PCR using primers representing BS2 (-542 to -535 bp relative to ATG) site, another previously reported E2F1-binding site. No DNA could be amplified from the chromatins, (data not shown), demonstrating that Par-4 and E2F1 specifically bind to the BS3 (-200 to -193 bp relative to ATG) site on the Smac promoter. In addition, we did not observe any Smac promoter pulled down by anti-Par-4 or anti-E2F1 antibody in hBMSCs without exposure to glutamate. Together, these findings strongly support the idea that Par-4 and E2F1 interact with a previously defined BS3 site within Smac promoter in vivo in glutamate-treated hBMSCs. Figure 5.Demonstration of in vivo binding of Par-4 and E2F1 to BS3 site (-200 to -193 bp relative to ATG) on the Smac/DIABLO promoter by chromatin immunoprecipitation. hBMSCs were treated with or without 100 microM glutamate for 24 h. Chromatin lysates were immunoprecipitated (IP) with either antibody against Par-4 or antibody against E2F1. The samples were processed as described under 'Materials and Methods' section. Immunoprecipitated DNA was amplified using primers representing the BS3 site (-200 to-193 bp relative to ATG) on Smac promoter. PCR analysis of the total input DNA was also preformed. Products of chromatin immunoprecipitation and PCR amplification were analysed by 2% agarose gel electrophoresis and beta-actin was performed as a negative control. Results are representative of three independent experiments.
###end p 70
###begin p 71
###xml 17 24 17 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIABLO</italic>
###xml 302 307 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 526 530 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
Demonstration of in vivo binding of Par-4 and E2F1 to BS3 site (-200 to -193 bp relative to ATG) on the Smac/DIABLO promoter by chromatin immunoprecipitation. hBMSCs were treated with or without 100 microM glutamate for 24 h. Chromatin lysates were immunoprecipitated (IP) with either antibody against Par-4 or antibody against E2F1. The samples were processed as described under 'Materials and Methods' section. Immunoprecipitated DNA was amplified using primers representing the BS3 site (-200 to-193 bp relative to ATG) on Smac promoter. PCR analysis of the total input DNA was also preformed. Products of chromatin immunoprecipitation and PCR amplification were analysed by 2% agarose gel electrophoresis and beta-actin was performed as a negative control. Results are representative of three independent experiments.
###end p 71
###begin title 72
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
The indirect transcriptional regulation of Par-4 on Smac was dependant on its COOH terminus-mediated interaction between Par-4 and E2F1 in hBMSCs
###end title 72
###begin p 73
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 455 460 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 515 520 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 640 644 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 677 681 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 783 788 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 810 815 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 841 848 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 978 982 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1115 1123 1107 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1180 1185 1172 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1223 1227 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1280 1285 1272 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1350 1354 1342 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1407 1412 1399 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1431 1436 1423 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1460 1464 1452 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1475 1484 1467 1476 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 1513 1518 1505 1510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1522 1526 1514 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1527 1533 1519 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIABLO</italic>
###xml 1607 1612 1599 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1638 1639 1630 1631 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1893 1898 1885 1890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1920 1925 1908 1913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2115 2122 2103 2110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2201 2205 2189 2193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 2386 2387 2372 2373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2433 2437 2419 2423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 2474 2475 2460 2461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2599 2604 2585 2590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 2626 2631 2608 2613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1484 3221 1476 3195 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="74">The indirectly regulation of <italic>Par-4</italic> on <italic>Smac</italic>/<italic>DIABLO</italic> promoter was dependant on its COOH terminus-mediated interaction between <italic>Par-4</italic> and E2F1 in the hBMSCs. (<bold>A</bold>) Luciferase activity assays. hBMSCs were co-transfected with pGL3-Smac-P-Luc reporter and pRL-CMV vector as an internal control for transfection efficiency. At the same time the cells were also transfected with either increasing amounts of pcDNA3.1-myc-<italic>Par-4</italic> or pcDNA3.1-myc-&#916;<italic>Par-4</italic>, or an empty pcDNA3.1 vector. Luciferase activity was determined at 24 h after transfection. Non-transfected cells were used as the background. All values were normalized for expression of <italic>Renilla</italic> luciferase and expressed as X-fold induction relative to the activity of pGL3-<italic>Smac</italic>-P-Luc reporter co-transfected with empty pcDNA3.1. Shown is a representative experiment of three independent experiments. Values are mean &#177; SE of three independent experiments. *<italic>P</italic> &lt; 0.05 versus cells co-transfected with pGL3-<italic>Smac</italic>-P-Luc reporter and empty pcDNA3.1. (<bold>B</bold>) Immunoprecipitations and Western blotting analysis of nuclear extracts in hBMSCs. Cells was transfected with pcDNA3.1-myc-<italic>Par-4</italic> or pcDNA3.1-myc-&#916;<italic>Par-4</italic>. After 24 h of transfection, nuclear proteins were extracted. Then the nuclear extracts, (0.15 mg protein/0.5 ml), were mixed with 10 &#956;l of anti-myc antibody or pre-immune serum. The mixtures were incubated at 4&#176;C for 1 h, and then 10 &#956;l protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Lanes 1 and 4, protein A gel only; lanes 2 and 5, cell lysate immunoprecipitated with anti-myc antibody; lanes 3 and 6, cell lysate incubated with pre-immune serum.</p>
###xml 1484 3221 1476 3195 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="74">The indirectly regulation of <italic>Par-4</italic> on <italic>Smac</italic>/<italic>DIABLO</italic> promoter was dependant on its COOH terminus-mediated interaction between <italic>Par-4</italic> and E2F1 in the hBMSCs. (<bold>A</bold>) Luciferase activity assays. hBMSCs were co-transfected with pGL3-Smac-P-Luc reporter and pRL-CMV vector as an internal control for transfection efficiency. At the same time the cells were also transfected with either increasing amounts of pcDNA3.1-myc-<italic>Par-4</italic> or pcDNA3.1-myc-&#916;<italic>Par-4</italic>, or an empty pcDNA3.1 vector. Luciferase activity was determined at 24 h after transfection. Non-transfected cells were used as the background. All values were normalized for expression of <italic>Renilla</italic> luciferase and expressed as X-fold induction relative to the activity of pGL3-<italic>Smac</italic>-P-Luc reporter co-transfected with empty pcDNA3.1. Shown is a representative experiment of three independent experiments. Values are mean &#177; SE of three independent experiments. *<italic>P</italic> &lt; 0.05 versus cells co-transfected with pGL3-<italic>Smac</italic>-P-Luc reporter and empty pcDNA3.1. (<bold>B</bold>) Immunoprecipitations and Western blotting analysis of nuclear extracts in hBMSCs. Cells was transfected with pcDNA3.1-myc-<italic>Par-4</italic> or pcDNA3.1-myc-&#916;<italic>Par-4</italic>. After 24 h of transfection, nuclear proteins were extracted. Then the nuclear extracts, (0.15 mg protein/0.5 ml), were mixed with 10 &#956;l of anti-myc antibody or pre-immune serum. The mixtures were incubated at 4&#176;C for 1 h, and then 10 &#956;l protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Lanes 1 and 4, protein A gel only; lanes 2 and 5, cell lysate immunoprecipitated with anti-myc antibody; lanes 3 and 6, cell lysate incubated with pre-immune serum.</p></caption>
###xml 3221 3221 3195 3195 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn426f6"/>
###xml 1475 3221 1467 3195 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="74">The indirectly regulation of <italic>Par-4</italic> on <italic>Smac</italic>/<italic>DIABLO</italic> promoter was dependant on its COOH terminus-mediated interaction between <italic>Par-4</italic> and E2F1 in the hBMSCs. (<bold>A</bold>) Luciferase activity assays. hBMSCs were co-transfected with pGL3-Smac-P-Luc reporter and pRL-CMV vector as an internal control for transfection efficiency. At the same time the cells were also transfected with either increasing amounts of pcDNA3.1-myc-<italic>Par-4</italic> or pcDNA3.1-myc-&#916;<italic>Par-4</italic>, or an empty pcDNA3.1 vector. Luciferase activity was determined at 24 h after transfection. Non-transfected cells were used as the background. All values were normalized for expression of <italic>Renilla</italic> luciferase and expressed as X-fold induction relative to the activity of pGL3-<italic>Smac</italic>-P-Luc reporter co-transfected with empty pcDNA3.1. Shown is a representative experiment of three independent experiments. Values are mean &#177; SE of three independent experiments. *<italic>P</italic> &lt; 0.05 versus cells co-transfected with pGL3-<italic>Smac</italic>-P-Luc reporter and empty pcDNA3.1. (<bold>B</bold>) Immunoprecipitations and Western blotting analysis of nuclear extracts in hBMSCs. Cells was transfected with pcDNA3.1-myc-<italic>Par-4</italic> or pcDNA3.1-myc-&#916;<italic>Par-4</italic>. After 24 h of transfection, nuclear proteins were extracted. Then the nuclear extracts, (0.15 mg protein/0.5 ml), were mixed with 10 &#956;l of anti-myc antibody or pre-immune serum. The mixtures were incubated at 4&#176;C for 1 h, and then 10 &#956;l protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Lanes 1 and 4, protein A gel only; lanes 2 and 5, cell lysate immunoprecipitated with anti-myc antibody; lanes 3 and 6, cell lysate incubated with pre-immune serum.</p></caption><graphic xlink:href="gkn426f6"/></fig>
###xml 870 873 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1027 1030 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1734 1737 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
To identify structural determinants of Par-4 responsible for its regulatory function on Smac transcription, we focused on investigating the role of the COOH terminus of Par-4, since a stretch of 70 amino acids at this region showed homology to a domain referred to as the death domain, which was also found in other pro-apoptotic proteins such as Fas, FADD and TNFR-1 (6,20). We engineered and constructed plasmids pcDNA3.1-myc-Par-4 and pcDN3.1-myc-DeltaPar-4, encoding a myc fusion protein containing full-length Par-4 protein or a deletion mutant, respectively, of which the latter lacked 70 amino acids at the COOH terminus. Then, pGL3-Smac-P-Luc reporter, which contained Smac promoter fragment (-600 to -100 bp relative to ATG), was cotransfected into hBMSCs with pcDNA3.1-myc-Par-4 or pcDNA3.1-myc-DeltaPar-4. Equal concentrations of Renilla reporter plasmid pRL-CMV were also co-introduced into cells as an internal control. Luciferase activities were measured and pGL3-Smac-P-Luc reporter activities normalized to pRL-CMV internal standard were presented in the histogram with arbitrary units. As shown in Figure 6A, cotransfection with increasing amounts of full-length Par-4 resulted in an increased activity of Smac promoter in a dose-dependent manner, whereas mutant Par-4 or empty vector failed to give rise to noticeable activation of Smac promoter. These data indicated the COOH terminus of Par-4 was essential for Par-4-mediated activation of Smac promoter. Figure 6.The indirectly regulation of Par-4 on Smac/DIABLO promoter was dependant on its COOH terminus-mediated interaction between Par-4 and E2F1 in the hBMSCs. (A) Luciferase activity assays. hBMSCs were co-transfected with pGL3-Smac-P-Luc reporter and pRL-CMV vector as an internal control for transfection efficiency. At the same time the cells were also transfected with either increasing amounts of pcDNA3.1-myc-Par-4 or pcDNA3.1-myc-DeltaPar-4, or an empty pcDNA3.1 vector. Luciferase activity was determined at 24 h after transfection. Non-transfected cells were used as the background. All values were normalized for expression of Renilla luciferase and expressed as X-fold induction relative to the activity of pGL3-Smac-P-Luc reporter co-transfected with empty pcDNA3.1. Shown is a representative experiment of three independent experiments. Values are mean +/- SE of three independent experiments. *P < 0.05 versus cells co-transfected with pGL3-Smac-P-Luc reporter and empty pcDNA3.1. (B) Immunoprecipitations and Western blotting analysis of nuclear extracts in hBMSCs. Cells was transfected with pcDNA3.1-myc-Par-4 or pcDNA3.1-myc-DeltaPar-4. After 24 h of transfection, nuclear proteins were extracted. Then the nuclear extracts, (0.15 mg protein/0.5 ml), were mixed with 10 mul of anti-myc antibody or pre-immune serum. The mixtures were incubated at 4degreesC for 1 h, and then 10 mul protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Lanes 1 and 4, protein A gel only; lanes 2 and 5, cell lysate immunoprecipitated with anti-myc antibody; lanes 3 and 6, cell lysate incubated with pre-immune serum.
###end p 73
###begin p 74
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DIABLO</italic>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 436 441 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 631 638 627 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 717 721 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 902 903 896 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 949 953 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 990 991 984 985 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1115 1120 1109 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1142 1147 1132 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 250 253 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The indirectly regulation of Par-4 on Smac/DIABLO promoter was dependant on its COOH terminus-mediated interaction between Par-4 and E2F1 in the hBMSCs. (A) Luciferase activity assays. hBMSCs were co-transfected with pGL3-Smac-P-Luc reporter and pRL-CMV vector as an internal control for transfection efficiency. At the same time the cells were also transfected with either increasing amounts of pcDNA3.1-myc-Par-4 or pcDNA3.1-myc-DeltaPar-4, or an empty pcDNA3.1 vector. Luciferase activity was determined at 24 h after transfection. Non-transfected cells were used as the background. All values were normalized for expression of Renilla luciferase and expressed as X-fold induction relative to the activity of pGL3-Smac-P-Luc reporter co-transfected with empty pcDNA3.1. Shown is a representative experiment of three independent experiments. Values are mean +/- SE of three independent experiments. *P < 0.05 versus cells co-transfected with pGL3-Smac-P-Luc reporter and empty pcDNA3.1. (B) Immunoprecipitations and Western blotting analysis of nuclear extracts in hBMSCs. Cells was transfected with pcDNA3.1-myc-Par-4 or pcDNA3.1-myc-DeltaPar-4. After 24 h of transfection, nuclear proteins were extracted. Then the nuclear extracts, (0.15 mg protein/0.5 ml), were mixed with 10 mul of anti-myc antibody or pre-immune serum. The mixtures were incubated at 4degreesC for 1 h, and then 10 mul protein A Sepharose beads were added. The mixtures were incubated for 1 h and, after being washed, the beads were submitted for western blotting analysis with anti-E2F1 antibody. Lanes 1 and 4, protein A gel only; lanes 2 and 5, cell lysate immunoprecipitated with anti-myc antibody; lanes 3 and 6, cell lysate incubated with pre-immune serum.
###end p 74
###begin p 75
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 341 346 341 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 433 437 433 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 587 592 587 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 615 623 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 700 705 700 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 748 753 748 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 864 869 864 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 931 936 931 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 977 985 977 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 1061 1066 1061 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1071 1076 1071 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1156 1161 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1172 1177 1172 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1212 1216 1212 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1257 1262 1257 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1286 1290 1286 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
Although, as delineated previously (15), no evidence was provided that Par-4 could directly bind to DNA molecule, our above studies has demonstrated that Par-4 and E2F1 could form protein complex and bind to Smac promoter. Hence, we could set up a hypothesis that the COOH terminus of Par-4 might contribute to proteins complex formation of Par-4 and E2F1, and then via recruitment of E2F1 to Smac promoter, Par-4 induced indirectly Smac transcription. In order to further corroborate this hypothesis, we performed the co-immunoprecipitation assays for measuring the interaction between Par-4 and E2F1. As shown in Figure 6B (lane 2), from nuclear extracts of the cells transfected with pcDNA3.1-myc-Par-4 and following treated with glutamate, myc-Par-4 was immunoprecipitated using anti-myc antibody, and associated E2F1 were detected by immunoblotting. However, Par-4 deletion mutant, which lacked the COOH terminus of wild-type Par-4 protein, failed to associate with E2F1 (Figure 6B, lane 5). The findings validated the essentiality of the COOH terminus of Par-4 for Par-4-E2F1 complex formation. Taken together, we concluded that the COOH terminus of Par-4, by which Par-4 associated with E2F1 and bound to Smac promoter, was functionally required for Par-4-mediated activation of Smac promoter in hBMSCs.
###end p 75
###begin title 76
DISCUSSION
###end title 76
###begin p 77
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 520 521 520 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 522 527 522 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16 B17 B18">16&#8211;18</xref>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 667 668 667 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 732 737 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 943 948 943 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1026 1031 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 1106 1111 1106 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
In this study, we report for the first time that glutamate can induce apoptosis in hBMSCs by a mechanism involving pro-apoptotic gene Par-4. Glutamate-induced neurotoxicity is an important contributor in acute neuronal damages and in chronic neurodegenerative diseases (16,17). Therefore, implanted stem cells will be sure to suffer from glutamate-mediated injury. We observed that glutamate induced a dose- and time-dependent apoptosis in hBMSCs, which was consistent with previous studies carried out in neural cells (4,16-18). As a pro-apoptotic factor, Par-4 is initially identified as a product of gene upregulated in prostate tumour cells undergoing apoptosis (5). Recently, growing evidence show that increased expression of Par-4 also regulates neuronal apoptosis, especially when exposed to metabolic insults such as glutamate and intracellular calcium elevation (15,19). In the current study, we demonstrated that the suppression of Par-4 expression greatly attenuated apoptosis in glutamate-treated hBMSCs, whereas Par-4 overexpression increased the percentage of apoptotic cells, implying that Par-4 played a critical role in glutamate-induced hBMSCs apoptosis.
###end p 77
###begin p 78
###xml 261 266 261 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 741 746 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1004 1025 1004 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p73, Apaf1, noxa, bim</italic>
###xml 1030 1033 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">akt</italic>
###xml 1112 1117 1112 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22 B23 B24 B25 B26 B27">22&#8211;27</xref>
###xml 1203 1207 1203 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1295 1299 1295 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 1325 1327 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1408 1412 1408 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
Previously, several signal pathways, including WT1/Bcl-2, Fas/Fas ligand, PKC/p38 mitogen-activated protein kinase (MAPK), Ras/NF-kB, DAP-like or ZIP kinase (DIK/ZIP kinase), extracellular signal regulated-kinase (ERK), have been demonstrated to be involved in Par-4-mediated apoptosis (6,9,20,21). Our studies showed that Par-4 ectopic expression in hBMSCs resulted in increased release of Smac protein from mitochondria and elevation of Smac message RNA, suggesting a previously undefined transcriptional mechanism for Par-4-mediated Smac upmodulation. However, previous studies did not provide any evidence to support the direct interaction between Par-4 protein and Smac promoter. Our data showed that blocking endogenous E2F1 decreased Par-4-induced Smac transcription, indicating that both Par-4 and E2F1 were required for Smac transcription regulation. Numerous studies showed that ectopic expression of E2F1 induced apoptosis by different mechanisms. Apoptosis-related E2F1 target genes, such as p73, Apaf1, noxa, bim and akt, are involved in both p53-dependent and p53-independent apoptotic regulation (22-27). A recent study demonstrated that enhanced accumulation of nuclear E2F1 upregulated Smac expression and subsequently accelerated mitochondria-mediated apoptosis, implying that Smac was an E2F1 target gene (12). In agreement with the study, our data showed that the increased expression of Smac gene in glutamate-treated hBMSCs were E2F1-dependent, at least partially.
###end p 78
###begin p 79
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 832 836 832 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 950 954 950 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 283 288 <span type="species:ncbi:9606">human</span>
We further confirmed that both Par-4 and E2F1 proteins participated in the formation of a complex that bound to the BS3 site (-200 to -193 bp relative to ATG) on Smac promoter, which was previously identified as a site where E2F1 bound to and increased transcription of Smac gene in human H1299 non-small lung carcinoma cells (12). Our results indicated that this site was also employed to drive the transcription of Smac in hBMSCs. Similar mechanism of Par-4 mediated indirect transcriptional regulation was delineated by Sangeeta and colleagues as well. They demonstrated that Par-4 associated with WT1 and bound to the bcl-2 promoter to transcriptionally regulate Bcl-2 expression in an androgen-independent prostate cancer cell line (28). In particular, our results suggested that it was E2F1, not Par-4, that directly bound to Smac promoter in the DNA-proteins complex, which implied that Par-4, indirectly, exert its transcriptional control on Smac gene though interacting with E2F1.
###end p 79
###begin p 80
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 391 396 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 570 575 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
Consistent with previous studies (6,20), our study validated the functional significance of the COOH terminus of Par-4 protein in hBMSCs apoptosis. The COOH terminus of Par-4 protein containing a leucine zipper domain has been shown to be essential in Par-4 binding to PKC, WT1, ZIPK/Daxx and THAP, and their interactions promoted cell apoptosis (6,20,29). Here we showed that the mutant of Par-4, which lacked 70 amino acids at the COOH terminus, failed to co-immunoprecipitate with E2F1 protein, implying that this region was also required for the interaction between Par-4 and E2F1. With luciferase activity analysis, we found that the increased expression of Par-4 resulted in an increased activity of Smac promoter in a dose-dependent manner, whereas Par-4 mutant failed to active Smac promoter. Therefore, we further corroborated that the indirect transcripional regulation of Par-4 on Smac was depended on its COOH terminus-mediated interaction between Par-4 and E2F1.
###end p 80
###begin p 81
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
Recently, it was reported that the COOH terminus of or possibly the full-length Par-4 protein was not required for apoptosis in primary fibroblasts (30). This discrepancy may be due to the different cell types, since in the same experiment settings, depletion of Par-4 in HeLa cells conferred a significant resistant to various apoptotic agents (30).
###end p 81
###begin p 82
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Smac</italic>
###xml 289 294 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Par-4</italic>
In summary, we show that the proteins-DNA complex, containing Par-4 protein, E2F1 protein and Smac promoter, contributes to glutamate-induced apoptosis in hBMSCs. The Par-4 mediated indirect transcripional regulation on Smac gene depended on its COOH terminus-mediated interaction between Par-4 and E2F1. Our studies provide a further understanding of molecular mechanism in glutamate induced hBMSCs apoptosis, which benefit stem-cell therapy in ischemic brain damage.
###end p 82
###begin title 83
SUPPLEMENTARY DATA
###end title 83
###begin p 84
 are available at NAR Online.
###end p 84
###begin title 85
Supplementary Material
###end title 85
###begin title 86
[Supplementary Data]
###end title 86
###begin title 87
ACKNOWLEDGEMENTS
###end title 87
###begin p 88
This work was supported by Medical Grants of Scientific and Technological Development from the Health Department of Jiangsu Province in China (No. K200504), National Natural Science Foundation of China (30570863) and the Medical Academic Key Talent Program of Jiangsu Province in China (RC2007050). Funding to pay the Open Access publication charges for this article was provided by the first Affiliated Hospital of Nanjing Medical University.
###end p 88
###begin p 89
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 89
###begin title 90
REFERENCES
###end title 90
###begin article-title 91
Acute ischemic stroke treatment in 2007
###end article-title 91
###begin article-title 92
Acute ischemic stroke
###end article-title 92
###begin article-title 93
The neuropathology of acquired pre- and perinatal brain injuries
###end article-title 93
###begin article-title 94
Ca2+ signals and neuronal death in brain ischemia
###end article-title 94
###begin article-title 95
###xml 61 66 <span type="species:ncbi:9606">human</span>
Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4
###end article-title 95
###begin article-title 96
A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1
###end article-title 96
###begin article-title 97
The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C
###end article-title 97
###begin article-title 98
Cloning and characterization of Dlk, a novel serine/threonine kinase that is tightly associated with chromatin and phosphorylates core histones
###end article-title 98
###begin article-title 99
pH-induced folding of an apoptotic coiled coil
###end article-title 99
###begin article-title 100
Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology
###end article-title 100
###begin article-title 101
Mitochondria in apoptosis: past, present and future
###end article-title 101
###begin article-title 102
Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro
###end article-title 103
###begin article-title 104
Activin Receptor-like Kinase-7 Induces Apoptosis through Activation of MAPKs in a Smad3-dependent Mechanism in Hepatoma Cells
###end article-title 104
###begin article-title 105
Apoptosis by Par-4 in cancer and neurodegenerative diseases
###end article-title 105
###begin article-title 106
Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies
###end article-title 106
###begin article-title 107
The galanin-R2 agonist AR-M1896 reduces glutamate toxicity in primary neural hippocampal cells
###end article-title 107
###begin article-title 108
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons
###end article-title 108
###begin article-title 109
Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration
###end article-title 109
###begin article-title 110
PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein
###end article-title 110
###begin article-title 111
The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target
###end article-title 111
###begin article-title 112
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human ARF binds E2F1 and inhibits its transcriptional activity
###end article-title 112
###begin article-title 113
Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF
###end article-title 113
###begin article-title 114
Role of the p53-homologue p73 in E2F1-induced apoptosis
###end article-title 114
###begin article-title 115
Apaf-1 is a transcriptional target for E2F and p53
###end article-title 115
###begin article-title 116
Apaf-1 is a mediator of E2F-1-induced apoptosis
###end article-title 116
###begin article-title 117
Transcriptional regulation of AKT activation by E2F. Mol
###end article-title 117
###begin article-title 118
Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter
###end article-title 118
###begin article-title 119
Direct binding to ceramide activates protein kinase Czeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells
###end article-title 119
###begin article-title 120
Targeted ablation of Par-4 reveals a cell type-specific susceptibility to apoptosis-inducing agents
###end article-title 120

